Clsi GP28 A
Clsi GP28 A
Clsi GP28 A
Vol. 25 No. 7
Replaces GP28-P
Vol. 24 No. 9
The Clinical and Laboratory Standards Institute (CLSI) Most documents are subject to two levels of consensus—
(formerly NCCLS) is an international, interdisciplinary, “proposed” and “approved.” Depending on the need for
nonprofit, standards-developing, and educational field evaluation or data collection, documents may also be
organization that promotes the development and use of made available for review at an intermediate consensus
voluntary consensus standards and guidelines within the level.
healthcare community. It is recognized worldwide for the
Proposed A consensus document undergoes the first stage
application of its unique consensus process in the
of review by the healthcare community as a proposed
development of standards and guidelines for patient
standard or guideline. The document should receive a wide
testing and related healthcare issues. Our process is
and thorough technical review, including an overall review
based on the principle that consensus is an effective and
of its scope, approach, and utility, and a line-by-line review
cost-effective way to improve patient testing and
of its technical and editorial content.
healthcare services.
Approved An approved standard or guideline has achieved
In addition to developing and promoting the use of
consensus within the healthcare community. It should be
voluntary consensus standards and guidelines, we
reviewed to assess the utility of the final document, to
provide an open and unbiased forum to address critical
ensure attainment of consensus (i.e., that comments on
issues affecting the quality of patient testing and health
earlier versions have been satisfactorily addressed), and to
care.
identify the need for additional consensus documents.
PUBLICATIONS
Our standards and guidelines represent a consensus opinion
A document is published as a standard, guideline, or on good practices and reflect the substantial agreement by
committee report. materially affected, competent, and interested parties
obtained by following CLSI’s established consensus
Standard A document developed through the consensus
procedures. Provisions in CLSI standards and guidelines
process that clearly identifies specific, essential
may be more or less stringent than applicable regulations.
requirements for materials, methods, or practices for use
Consequently, conformance to this voluntary consensus
in an unmodified form. A standard may, in addition,
document does not relieve the user of responsibility for
contain discretionary elements, which are clearly
compliance with applicable regulations.
identified.
COMMENTS
Guideline A document developed through the
consensus process describing criteria for a general The comments of users are essential to the consensus
operating practice, procedure, or material for voluntary process. Anyone may submit a comment, and all comments
use. A guideline may be used as written or modified by are addressed, according to the consensus process, by the
the user to fit specific needs. committee that wrote the document. All comments,
including those that result in a change to the document when
Report A document that has not been subjected to
published at the next consensus level and those that do not
consensus review and is released by the Board of
result in a change, are responded to by the committee in an
Directors.
appendix to the document. Readers are strongly encouraged
CONSENSUS PROCESS to comment in any form and at any time on any document.
Address comments to the Clinical and Laboratory Standards
The CLSI voluntary consensus process is a protocol Institute, 940 West Valley Road, Suite 1400, Wayne, PA
establishing formal criteria for: 19087, USA.
• the authorization of a project VOLUNTEER PARTICIPATION
• the development and open review of documents Healthcare professionals in all specialties are urged to
• the revision of documents in response to comments volunteer for participation in CLSI projects. Please contact
by users us at exoffice@clsi.org or +610.688.0100 for additional
information on committee participation.
• the acceptance of a document as a consensus
standard or guideline.
GP28-A
ISBN 1-56238-563-1
Volume 25 Number 7 ISSN 0273-3099
Microwave Device Use in the Histology Laboratory; Approved
Guideline
Gary R. Login, DMD, DMSc
Ellyn S. Beary, BS
H. Skip Brown, BA, HT(ASCP)
Cheryl H. Crowder, BA, HTL(ASCP)
Maureen Doran, BA, HTL(ASCP)
Richard T. Giberson, BA, MS
H. M. Skip Kingston, PhD
Anthony Leong, MD
Max Robinowitz, MD
Steven E. Slap, BA, MA, MPhil
Franco Visinoni, PhD
Abstract
This document provides recommendations for quality assurance and safety procedures for microwave equipment use, and
provides a means to understand and troubleshoot conditions that contribute to variability in microwave-accelerated procedures in
human clinical, veterinary, and research histopathology laboratories. Safety issues unique to microwave instrumentation in
histopathology laboratory settings are emphasized. In addition, the document discusses microwave device process control,
procedure validation, and results verification.
Clinical and Laboratory Standards Institute (CLSI). Microwave Device Use in the Histology Laboratory; Approved Guideline.
CLSI document GP28-A (ISBN 1-56238-563-1). Clinical and Laboratory Standards Institute, 940 West Valley Road, Suite 1400,
Wayne, Pennsylvania 19087-1898 USA, 2005.
The Clinical and Laboratory Standards Institute consensus process, which is the mechanism for moving a document through
two or more levels of review by the healthcare community, is an ongoing process. Users should expect revised editions of any
given document. Because rapid changes in technology may affect the procedures, methods, and protocols in a standard or
guideline, users should replace outdated editions with the current editions of CLSI/NCCLS documents. Current editions are
listed in the CLSI catalog, which is distributed to member organizations, and to nonmembers on request. If your organization is
not a member and would like to become one, and to request a copy of the catalog, contact us at: Telephone: 610.688.0100; Fax:
610.688.0700; E-Mail: exoffice@clsi.org; Website: www.clsi.org
Number 7 GP28-A
This publication is protected by copyright. No part of it may be reproduced, stored in a retrieval system,
transmitted, or made available in any form or by any means (electronic, mechanical, photocopying,
recording, or otherwise) without prior written permission from Clinical and Laboratory Standards
Institute, except as stated below.
Clinical and Laboratory Standards Institute hereby grants permission to reproduce limited portions of this
publication for use in laboratory procedure manuals at a single site, for interlibrary loan, or for use in
educational programs provided that multiple copies of such reproduction shall include the following
notice, be distributed without charge, and, in no event, contain more than 20% of the document’s text.
Permission to reproduce or otherwise use the text of this document to an extent that exceeds the
exemptions granted here or under the Copyright Law must be obtained from Clinical and Laboratory
Standards Institute by written request. To request such permission, address inquiries to the Executive Vice
President, Clinical and Laboratory Standards Institute, 940 West Valley Road, Suite 1400, Wayne,
Pennsylvania 19087-1898, USA.
Suggested Citation
(Clinical and Laboratory Standards Institute. Microwave Device Use in the Histology Laboratory;
Approved Guideline. CLSI document GP28-A [ISBN 1-56238-563-1]. Clinical and Laboratory Standards
Institute, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898 USA, 2005.)
Proposed Guideline
February 2004
Approved Guideline
February 2005
ISBN 1-56238-563-1
ISSN 0273-3099
ii
Volume 25 GP28-A
Committee Membership
iii
Number 7 GP28-A
Staff
Donna M. Wilhelm
Editor
Melissa A. Lewis
Assistant Editor
The Clinical and Laboratory Standards Institute (CLSI) and the Subcommittee on Microwave Ovens
acknowledge the contributions of Mr. Steven E. Slap, BA, MA, M Phil. Steve was one of the early
promoters of the first commercial laboratory microwave device for histology. His energy and foresight
stimulated many educational seminars, and he introduced many histologists to the benefits of microwave
methods.
iv
Volume 25 GP28-A
Contents
Abstract ....................................................................................................................................................i
1 Scope..........................................................................................................................................1
2 Introduction................................................................................................................................1
3 Definitions .................................................................................................................................2
References.............................................................................................................................................32
v
Number 7 GP28-A
vi
Volume 25 GP28-A
Foreword
The ease and rapid pace with which microwaves have entered the clinical laboratory are raising many
questions for laboratory administrators. Are laboratory personnel aware of and trained in safety issues
unique to microwaves? Do laboratory directors have a quality assurance program for microwave
procedures? Does the leadership of the national societies that represent medical and research communities
have the information they need to respond to local and national regulatory agencies regarding the safe and
efficacious use of microwave technology? Are equipment manufacturers promoting equipment that meets
the highest safety standards?
Several basic science and clinical research laboratories in North America, Europe, Asia, and Australia
working independently during the past 31 years have identified important principles for using microwave
technology reliably in laboratory medicine. This guideline emphasizes the scientific principles and
practices involving the safe and effective use of microwave ovens in the histology laboratory. However,
it is also important to be aware of national and local governmental regulatory requirements before
microwave ovens are selected and used in clinical laboratories. The guideline only provides examples of
the regulatory requirements that are current in the United States. Users in other countries are advised to
consult with their national and local authorities for requirements.
Readers wishing for a quick start are directed to the following sections:
Key Words
vii
Number 7 GP28-A
viii
Volume 25 GP28-A
1 Scope
This CLSI guideline is written for multiple audiences, including: laboratory technicians, microwave
device manufacturers, microwave device resellers, compliance and safety officials, and administrators.
The goals of this document are to 1) provide a scientific basis for reproducible sample preparation of
biological specimens for diagnostic purposes; 2) advise laboratory personnel on the best safety guidelines;
and 3) discuss the limitations of domestic microwave ovens in a hospital laboratory. Original sources are
cited in the References section for those individuals seeking additional information.
NOTE: The reader is encouraged to supplement the information in this document with continuing
education courses on microwave device safety and use.
2 Introduction
Microwave-accelerated sample preparation of biological specimens is a field that continues to grow
rapidly as evidenced by the number of innovative articles written each year. The reason for this increase
in the microwave literature is simple. Microwave-accelerated procedures are useful in almost every step
of sample preparation for microscopy. Microwave procedures speed up reaction processes and save time.
Even more important, microwave procedures improve the retention of soluble antigens and often preserve
antigen immunoreactivity better than conventional fixation methods.1,2 In short, microwave-accelerated
techniques can be used to improve the efficiency of a variety of histopathology laboratory procedures,
such as fixation, decalcification, processing of specimens for paraffin wax or resin embedding, and
staining. Hundreds of laboratory procedures using microwave devices for histopathology have been
published.1,3-5 A brief list of these procedures is provided in Table 1.
©
Clinical and Laboratory Standards Institute. All rights reserved. 1
Number 7 GP28-A
Three types of microwave devices are being used in a histopathology laboratory setting: 1) microwave
instruments specifically designed and certified as medical devices; 2) commercial grade microwave
devices converted for laboratory/clinical use; and 3) consumer household microwave units modified for
laboratory/clinical use. Laboratory microwave devices are designed with exhaust fans and safety features
to protect the operator, sensors to protect the instrument, and sophisticated temperature monitoring and
intricate electronics that allow improved quality control of the specimen. Household microwave units are
designed for food preparation, and they are not certified for laboratory use unless they meet the
requirements outlined in Section 4.
All three types of microwave devices have a large chamber in which samples are heated. Large-chamber
microwave devices are often described in the microwave literature as “large-cavity” or “multimodal
devices.” For the purposes of this document, we will use the term “large-cavity microwave devices.”
Several features have been added to microwave devices to reduce heating damage to biological specimens
and microwave equipment (see Table 2). Manufacturers of laboratory microwave equipment have
improved temperature control by adding temperature probes with feedback systems for process
automation, specialized power supplies for generation of microwave power,4,6-10 controllable magnetron
duty cycles,3 and variable power output.11 Highly specialized microwave devices have platforms with
very high rotational speed,12 vacuum and pressure cycling,13-15 and hybrid equipment combining
ultrasound and microwave irradiation.16
To date, there are no regulations or benchmarks specifically for microwave devices in the clinical
laboratory. There are, however, many regulations regarding electrical safety and general laboratory
equipment safety that include microwave devices (see Section 4 for more details). In addition, the
potential to overheat and damage diagnostic biological specimens in microwave procedures is great (e.g.,
tissue shrinkage, denatured connective tissue, pyknotic nuclei). The need for guidelines and quality
assurance for microwave procedures is well recognized.4,17-26
3 Definitions
This section provides a brief list of the most common terms and definitions to facilitate reading the
microwave literature. A detailed report of terminology related to microwave safety has been published.27
Accuracy (of measurement) – Closeness of the agreement between the result of a measurement and a
true value of the measurand (VIM93).28
Calorie (C) – 1) The amount of heat it takes to raise the temperature of 1000 grams or 1 kg of water one
degree centigrade; NOTE: A Calorie is actually a kilocalorie or 1000 calories; 2) calorie (c) – The
amount of heat it takes to raise the temperature of 1 gram of water 1 degree centigrade; NOTE: The
cal/min is the unit of heat per minute.
Cathode – Negatively charged conductor that is the source of electrons in an electrical device.
Conduction – The flow of heat by conduction occurs via collisions between atoms and molecules in the
substance and the subsequent transfer of kinetic energy; NOTE: When there exists a temperature
gradient within a body, heat energy will flow from the region of high temperature to the region of low
temperature.
Convection – The flow of heat through a bulk, macroscopic movement of matter from a hot region to a
cool region.
Dielectric constant – The measure of a sample’s ability to obstruct the microwave energy as it passes
through the medium; the loss (dielectric) factor measures the sample’s ability to dissipate that energy;
NOTE: The term “loss” is used to indicate the amount of input microwave energy that is lost to the
sample by being dissipated as heat in the sample.
Diode – A device that conducts electric current run in one direction only.
Dipolar molecules – Molecules that are configured such that electrons favor one region of the molecule,
resulting in an uneven spatial distribution of electrons and charge so that one side is slightly negatively
charged relative to the somewhat more positively charged other side.
Dipole rotation – The net alignment, due to the electric field, of molecules in the sample that have
permanent or induced dipole moments.
Duty cycle (magnetron cycling) – Microwave power can be applied continuously but is usually pulsed.
The power output of the magnetron is controlled by “cycling” the magnetron on and off at full power for
some fraction of time to obtain an average power level. The duty cycle of a magnetron is the time the
magnetron is ‘on’ divided by the total time of the cycling period; NOTE: Domestic microwave devices
have relatively long cycling periods based on intervals of 1/6 min. (10 seconds) and longer as compared
to laboratory analytical grade microwave equipment which has cycling periods of 1/60 min. (1 second),
making heat control more difficult in household microwave devices.
Hertz – The derived Standardized International (SI) Units of inductance, defined as the frequency of one
cycle per second, having units of S-l (reciprocal seconds).
Inductance – A magnetic field produced by the presence of an electric current.
Ionic conduction – The conductive (i.e., electrophoretic) migration of dissolved ions in the applied
electromagnetic field.
Magnetron – A cylindrical diode with an anode and a cathode; NOTES: a) Superimposed on the diode is
a magnetic field that is aligned with the cathode; b) A ring of mutually coupled resonant cavities is in the
©
Clinical and Laboratory Standards Institute. All rights reserved. 3
Number 7 GP28-A
anode so a potential of several thousand volts is reached across the diode; c) The released electrons, under
the influence of the magnetic field, resonate, and the magnetron oscillates.
Microwave field – Electromagnetic, nonionizing radiation that is produced by the magnetron; NOTES:
a) The microwave field refers to the density of microwave energy in a defined space; b) This microwave
energy density in a space is sometimes referred to as “field strength.”
Microwaves – Electromagnetic energy between far infrared (IR) and radio waves that corresponds to
wavelengths of 1 cm to 1 m; NOTE: The frequency range of these sources is between 30 GHz and 300
MHz with a frequency of 2450 MHz being the most common.
Mode stirrer – A device that disrupts standing microwave patterns and distributes the microwave energy
more homogeneously throughout a microwave cavity.
Power output of the magnetron – A measure of heat per unit time, i.e., 1 W = 14.33 cal/min; NOTE:
The microwave energy output from the magnetron is generally measured in watts.
Reflected power – The power that occurs when the traveling electromagnetic waves are reflected and the
flow of energy is partly in the reverse direction; NOTES: a) Reflected microwave energy can result in
overheating or a deficiency of microwave energy in localized areas; b) Devices that remove reflected
microwaves have been designed to protect the magnetron from microwave energy reflected back into the
wave-guide.
Reproducibility – Precision under conditions where test results are obtained with the same method on
identical test items in different laboratories with different operators using different equipment (ISO 5725-
1).29
Sample – One or more parts taken from a system and intended to provide information on the system,
often to serve as a basis for decision on the system or its production (ISO 15189)30; NOTE: For example,
a volume of serum taken from a larger volume of serum (ISO 15189).
Specific heat – The heat required to raise the temperature of one gram of a substance one degree
centigrade.
Specimen – The discrete portion of a body fluid or tissue taken for examination, study, or analysis of one
or more quantities or characteristics to determine the character of the whole.
Thermodynamic – The branch of physics concerned with the conversion of different forms of energy; it
is the study of the effects of work, heat, and energy on a system.
Watt – 1) In electrical terms, one watt is the power produced by a current of one ampere flowing through
an electric potential of one volt; 2) The power which in one second gives rise to energy of one joule;
NOTES: a) The SI unit of power; power is the rate at which work is done, or (equivalently) the rate at
which energy is expended; b) One watt is equal to a power rate of one joule (force per distance) of work
per second of time.
Wave-guide – A device that delivers the microwave energy from the magnetron to the microwave cavity.
©
4 Clinical and Laboratory Standards Institute. All rights reserved.
Volume 25 GP28-A
It is essential that microwave units be operated in a manner that ensures maximum safety to the operator
and laboratory personnel. In the U.S., many regulatory bodies (e.g., Food and Drug Administration
[FDA], Occupational Safety and Health Administration [OSHA]) require compliance with provisions of
the Code of Federal Regulations (CFR) and testing laboratories and certification organizations (e.g.,
Underwriters’ Laboratories [UL]). One such provision for laboratory equipment is 29 CFR 1910.399.
This requirement states that an installation of equipment (including household microwave ovens) could
be acceptable (to OSHA) and approved within the meaning of Subpart S requirement if it is accepted,
certified, listed, labeled, or otherwise determined to be safe by a nationally recognized testing laboratory
(NRTL). However, even if a device or equipment is “approved,” 29 CFR 1910.303(b) (2) requires that the
“listed or labeled equipment should be used or installed in accordance with any instructions included in
the listing or labeling.”
NOTE: Current FDA and OSHA regulations do not prevent anyone from purchasing and using a
microwave oven for other than its intended purpose. However, once a household or commercial
microwave unit has been modified for use in a clinical laboratory (i.e., it is no longer considered to have
been “designated to heat, cook, or dry food”), the original oven manufacturer is neither liable nor
responsible for the compliance of the modified ovens. Thus, the person who is modifying the oven is
subject to the provisions of Chapter V, Subchapter A- Drugs and Devices of the Federal Food, Drug, and
Cosmetic (FFD&C) Act.
Microwave-accelerated sample preparation is not exempt from traditional safety considerations, and
references to general laboratory safety are available.31 (Please refer to the most current edition of
CLSI/NCCLS document GP17—Clinical Laboratory Safety for additional information.)
In this section, the unsafe conditions and practices that may occur in the preparation of biological
specimens related to the operation of microwave devices are evaluated. A detailed discussion of relevant
equipment standards, safety code requirements, and general safety guidelines relating to laboratory
microwave systems is presented. A recommendation for periodic updating of safety information is
included.
NOTE: Readers are also encouraged to consult frequently updated resources on general microwave
laboratory safety for additional information.32
Hazards related to microwave use for specimen preparation are organized into five groups: 1) radiation
exposure standards and regulations; 2) electrical precautions; 3) biological precautions; 4) chemical
environment; and 5) high-temperature hazards.
Studies into the biological effects of microwave radiation exposure have been extensively detailed (~1000
references) in several reviews dealing with scientific, industrial, and medical applications.27 Currently in
the United States, microwave energy exposure from all large-cavity microwave devices operating at 2450
MHz is limited to 5 mW/cm2 at a distance of 5 cm from any surface of a product. 27 The maximum human
exposure to radio frequency (RF) energy for operating in a safe workplace is <10 mW/cm2 averaged over
©
Clinical and Laboratory Standards Institute. All rights reserved. 5
Number 7 GP28-A
a six-minute period.33 Although no microwave leakage limit exists specifically for laboratory and
scientific units, manufacturers of these products are subject to other Federal Drug Administration (FDA)
regulations.34-36
Microwave device performance standards are incorporated in the Radiation Control for Health and Safety
Act, Federal Law enacted in 1968.27 The FDA regulates microwave-heating devices under two different
provisions of the FFD&C Act. Under the FFD&C Act, they are regulated as electronic products in
Chapter V, subchapter C—Electronic Product Radiation Control. Under the Radiation Control
provisions, the FDA regulates the manufacture of electronic products but not their use (written
communication, April 2002). If the microwave-heating device is designed for heating, cooking, or drying
food and “manufactured for use in homes, restaurants, food vending, or service establishments…” then it
is subject to the Federal Performance Standards for Microwave and Radiofrequency Emitting Products,
21 CFR 1030.10 (written communication, April 2002).
Ovens and Pacemakers: At one time there was concern that leakage from microwave ovens could
interfere with certain electronic cardiac pacemakers. There was similar concern about pacemaker
interference from electric shavers, auto ignition systems, and other electronic products. Because there are
so many other products that also could cause this problem, FDA does not require microwave ovens to
carry warnings for people with pacemakers. The problem has been largely resolved, since pacemakers are
now designed so they are shielded against such electrical interference. However, patients with
pacemakers may wish to consult their physicians about this electrical interference.
Many references to other international standards are available and should be consulted if the user’s
geographical location places the microwave under other jurisdictions.37
This section provides regulatory information primarily for microwave device manufacturers, microwave
device resellers, compliance and safety officials, and administrators. The information below may also
assist laboratory technicians making purchasing decisions of microwave devices that are in compliance
with FDA and OSHA regulations.
In the U.S., OSHA regulations require that, if microwave equipment is modified or the integrity of a
safety device is violated, the product must be demonstrated to be safe by measuring the microwave
radiation exposure potential.27 As long as damage, wear, or misuse have not lessened the effectiveness of
the instrument, all the exposure limits of various national/international standards are met or exceeded. 27,38
The FFD&C Act defines a medical device as an instrument, apparatus, implement, machine, contrivance,
implant, in vitro reagent, or other similar or related article including a component or accessory that is
intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or
prevention of disease, in man or other animals.39 A summary of FDA regulations of Microwave
Equipment is in Table 3.
©
6 Clinical and Laboratory Standards Institute. All rights reserved.
Volume 25 GP28-A
Microwave Heating
for Medical and/or X X X X
Clinical Use
Manufacturers subject to the FDA regulations include original manufacturers, importers, and persons who
remanufacture products for distribution to others.27 Remanufacturing includes adapting a product for a
new or intended use, such as converting household cooking devices for laboratory use, and reselling
them.27
This section provides electrical safety information primarily for microwave device manufacturers,
microwave device resellers, and compliance and safety officials, and administrators.
Laboratory technicians are advised that according to OSHA household microwave ovens do not meet the
more stringent door seal and endurance tests required for applications outside of the home.
Microwave devices, like any appliance used in a laboratory, must be certified as electrically safe for
laboratory use by a recognized testing laboratory (e.g., Underwriters Laboratories [UL], Canadian
Standards Association [CSA], or Conformité Européene [ ], which means European Conformity). The
unit must be grounded in accordance with the manufacturer’s specifications.27 In accordance with the
policy of the end user’s institution, qualified service technicians must do electrical repairs. The use of
metal accessories is not recommended unless they were designed and tested for use with the particular
microwave equipment and are used according to the manufacturer’s specifications.
©
Clinical and Laboratory Standards Institute. All rights reserved. 7
Number 7 GP28-A
UL-listed household and commercial-use microwave ovens are evaluated to the applicable electrical
requirements of the UL 923 standard for safety of microwave cooking appliances. The construction and
type test requirements are substantially similar for household and commercial types except for the more
stringent door seal and endurance tests for commercial types. Laboratory equipment is evaluated to the
applicable requirements of UL 61010A-1, Standard for Safety of Electrical Equipment for Laboratory
Use; Part 1: General Requirements (written communication, April 2002).
The safety instructions in UL 923 state, “Use this appliance only for its intended use as described in the
manual. Do not use corrosive chemicals or vapors in this appliance. This type of oven is specifically
designed to heat, cook, or dry food. It is not designed for industrial or laboratory use” (written
communication, August 2002).
It is often impossible to know what might be infectious; therefore, all specimens are to be treated as
potentially infectious and handled according to “standard precautions.” Standard precautions are
guidelines that combine the major features of “universal precautions” and “body substance isolation”
practices. Standard precautions cover the transmission of any pathogen and thus, are more comprehensive
than universal precautions, which are intended to apply only to transmission of blood-borne pathogens.
Standard precaution and universal precaution guidelines are available from the U.S. Centers for Disease
Control and Prevention (Guideline for Isolation Precautions in Hospitals. Infection Control and Hospital
Epidemiology. CDC. 1996;Vol 17;1:53-80.), (MMWR 1987; 36(suppl 2S):2S-18S), and (MMWR
1988;37:377-382, 387-388). For specific precautions for preventing the laboratory transmission of blood-
borne infection from laboratory instruments and materials, and recommendations for the management of
blood-borne exposure, refer to CLSI/NCCLS document M29—Protection of Laboratory Workers from
Occupationally Acquired Infections.
The utility of using microwave energy to destroy pathogens requires further study. Therefore, until more
data becomes available, all potentially infectious specimens must be handled with standard precautions
during and after the use of microwave irradiation. The inside walls of the microwave device should be
cleaned with a nonabrasive, disinfectant solution. Chemical germicides registered with and approved by
the EPA as “sterilants” can be used for decontamination in accordance with the manufacturer’s
instructions. Microwave devices that are used for any laboratory procedure should not be used to heat
food for human or animal consumption.
Safety of the technician is the most important consideration in the sample preparation process. Microwave
energy accelerates the rate of sample reactions, but it does not alter the fundamental chemistry involved.
The technician is advised that any reagents that are dangerous to heat by conventional methods are likely
to be more dangerous when heated in a microwave device because of the rapid rate of heating. If there is
any concern about flammability of a reagent do not use it in a microwave oven. Combinations of reagents
that are explosive, or so highly reactive as to be uncontrollable, fall into this category. Please check the
Material Safety Data Sheet (MSDS) or with the manufacturer of the microwave device to determine
safety and test data for a particular reagent or procedure to avoid unreasonable, hazardous misuse of
laboratory microwave systems. 27,32 See http://www.sampleprep.duq.edu/dir/safety.html
Handling chemicals in a microwave environment requires special considerations. Aqueous chemicals that
are dangerous at room temperature (e.g., formaldehyde, osmium tetroxide, lead acetate) pose an added
danger during and immediately after microwave irradiation. Chemicals that are warmed will volatilize in
the microwave cavity. Opening the door of a microwave device that is not properly vented will allow the
volatilized chemical vapors to enter the laboratory environment. Some types of ventilation hoods can
function properly when a microwave device without an exhaust fan is properly placed in the system. End
©
8 Clinical and Laboratory Standards Institute. All rights reserved.
Volume 25 GP28-A
users should consult a qualified ventilation specialist to determine if the laboratory hood and ventilation
system are capable of functioning safely with the intended microwave device. Laboratory grade
microwave devices equipped with exhaust fans and connected to an approved ventilation system will
reduce the risk of chemical exposure hazard during microwave heating.
The use of organic solvents and caustic chemicals may accelerate the deterioration of door seals and
safety interlock switches.42 Transport of heated chemicals outside of the microwave cavity or ventilation
hood should be done in a closed container. Chemically resistant gloves and goggles should be used to
handle all containers containing hazardous materials that have been microwaved. All chemical spills
should be handled with appropriate chemical spill precautions and the surfaces cleaned off immediately to
prevent damage to the unit.
NOTE: Do not use corrosive chemicals or vapors in microwave devices unless directed so in the device
manual.
Engineering controls, work practices, and personal protective equipment should be used in accordance
with local and regional regulations (e.g., OSHA) and the end user’s institutional standards. Additional
information about chemical safety according to OSHA standards can be found in documents such as
Occupational Exposure to Hazardous Chemicals in Laboratories (29 CFR 1910.1450), Flammable and
Combustible Liquids standard (29 CFR 1910.106), permissible limits in the Air Contaminants (29 CFR
1910.1000), and specific chemical standards in 29 CFR Subpart Z that apply. For safety concerns within
the hospital, laboratories that must comply with 29 CFR 1910.1450 must designate “personnel
responsible for implementation of the Chemical Hygiene Plan including assignment of a Chemical
Hygiene Officer, and if appropriate, establishment of a Chemical Hygiene Committee” (written
communication, August 2002).
Microwave protocols for histology laboratories should specify the use of containers that are vented to
prevent pressurization during microwave heating. Containers must be microwave compatible and not
contain metal parts that may reflect microwave energy or cause arcing of microwave power. Although
special containers are available for pressurization in a microwave, these are generally designed and used
for acid digestion of samples for analytical elemental analyses27 or for high temperature sterilization and
antigen retrieval.
A protective thermal glove should be used when removing samples that are irradiated to high
temperatures in a microwave (i.e., heated solutions may conductively heat the container). Spontaneous
“volcanic” boiling can occur in liquids after microwave irradiation and upon removal of the sample from
the microwave. This is attributed to localized super heating of the liquid which occurs secondary to
bubble nucleation and coalescence of dissolved gases as a result of microwave heating. 27,43 The risk of
spontaneous boil over in histopathology applications is more likely during high temperature heating
procedures, such as microwave staining and antigen retrieval processes.
©
Clinical and Laboratory Standards Institute. All rights reserved. 9
Number 7 GP28-A
©
10 Clinical and Laboratory Standards Institute. All rights reserved.
Volume 25 GP28-A
A safety inspection of the microwave device should be done on a regular basis, determined by the
laboratory supervisor and the institution’s safety officer. Table 5 provides a template of a microwave
device survey data sheet for use in microwave safety inspection.
Date:
Department: Responsible Person:
Location of Unit: Serial/ID#:
Survey Instrument: Control Limit (1): 5 mW/cm2
Inspection Checklist
Yes No N/A
Warning sign for radio frequency radiation posted
Additional information or precautions included on warning label of microwave
Safety interlock prevents the device from operating if the door is opened
Instrument is inspected periodically to ensure proper condition (e.g., corrosion)
Device is maintained in a sanitary condition
A qualified authority certified in using microwave leakage instrumentation should determine microwave
leakage of all microwave devices in the laboratory. Inexpensive microwave leakage detectors typically
result in false-positive leakage readings and are not recommended. Call a qualified service representative
to determine the cause and repair of any leakage. Do not attempt to repair the device yourself. DO NOT
USE THE DEVICE UNTIL IT HAS BEEN REPAIRED.
The institutional radiation safety officer will typically take leakage readings at a distance of 5 cm from the
surface of the unit with a 100 mL water load in place while the device is operating at maximum power
(see Figure 1). In addition to surveying leakage around the door and frame, other locations that must be
checked for leakage include outlets in the device for ventilation tubes and thermocouple lines. Table 6
provides a template for recording microwave leakage readings.
1 2 3
4 5 6
7 8 9
©
Clinical and Laboratory Standards Institute. All rights reserved. 11
Number 7 GP28-A
Position # Reading
1
2
3
4
5
6
7
8
9
The principal features of a microwave unit are illustrated in the cutaway diagram shown in Figure 2. The
primary components include: (A) control pad; (B) power supply; (C) magnetron; (D) wave guide; (E)
distributor; and (F) unit door and walls.47, 48
Power level in most microwave devices is controlled by switching the magnetron on and off according to
a duty cycle.1,3,48 For example, a typical 600-W unit with a 30-second duty cycle can be made to deliver
an average of 300 W by switching the magnetron on and off every 15 seconds.1,3,48 Long duty cycles (i.e.,
>10 seconds) are undesirable in biological sample preparation where samples may not heat between
switching steps. This is, therefore, one factor that must be considered in adapting certain microwave
devices for tissue sample applications.47 Some microwave devices have a more sophisticated control
system in which the magnetron power is actually variable and not dependent upon switching the
magnetron on and off.4
A wave-guide [see Figure 2 (D)] is a rectangular channel made of sheet metal. Its reflective walls allow
the transmission of microwaves from the magnetron to the microwave cavity or applicator.47,48
The reflective walls of the microwave cavity are necessary to prevent leakage of radiation and to increase
the efficiency of the unit. There is rarely a perfect match between the frequency used and the resonant
frequency of the load. Therefore, if the walls reflect the energy, absorbance is increased because energy
passes through the sample more often and can be partially absorbed on each passage.43 This can be
particularly important if the sample is dimensionally small. If too much energy is reflected back into the
wave-guide, the magnetron may be damaged. Most commercial units are protected by an automatic
cutoff. There may also be protection in the form of a circulator that directs reflected energy into a dummy
load.47,48
NOTE: If working with small loads, poorly absorbing loads, or at high powers, then a dummy load (for
example, a beaker of water) should be placed in the cavity (unless instructed otherwise by the equipment
manufacturer) to absorb the excess energy generated.1,3, 48
In the absence of any smoothing mechanism, the electric field pattern produced by the standing waves set
up in the cavity may be extremely complex. Some areas may receive large amounts of energy while
others may be almost neglected. To ensure that the incoming energy is smoothed out in the cavity, a
distributor (a reflective, fan-shaped paddle) is sometimes used [see Figure 2 (E)]. Some microwave
devices are also supplied with a turntable, which ensures that the samples are moved in and out of areas of
hot and cold spots, as long as the sample is not centrally located on the turntable.1,3, 48
The important features of the magnetron, in which the microwaves are generated, are shown in Figure 3.
A magnetron is a thermionic diode having an anode and a directly heated cathode.47 As the cathode is
heated, electrons are released and are attracted toward the anode (path indicated by the arrow). The anode
(gray area of diagram) is made up of an even number of small cavities, each of which acts as a tuned
circuit.47,48 The gap across the end of each cavity is capable of storing electric charge. The anode is
therefore a series of electric circuits that are tuned to oscillate at a specific frequency or its overtone.47 A
very strong magnetic field (X shown in Figure 3) is induced axially through the anode assembly and has
the effect of bending the path of the electrons as they travel from the cathode to the anode. As the
deflected electrons pass through the cavity gaps, they induce a small charge into the tuned circuit,
resulting in oscillation in the cavity. Once the oscillation has achieved sufficiently high amplitude, it is
taken off the anode via an antenna/aperture. Of the available power used by the magnetron (e.g., between
3000 and 4000 W), only half of this wattage is converted to electromagnetic energy. The remainder is
converted into heat and must be dissipated through air- or water-cooling.47 Microwave units may have
more than one magnetron and/or wave distribution system.
©
Clinical and Laboratory Standards Institute. All rights reserved. 13
Number 7 GP28-A
Figure 3. Magnetron
In conventional histology procedures, “standard devices” (such as hot plates, heating mantles, heating
blocks, and conventional heat laboratory units) conduct heat to the reaction vessel. The solution is
subsequently heated only through direct contact with the vessel walls.49,50 The heat is distributed via
convection currents throughout the reagent-sample mixture. Because of the nature of this process, these
heating methods are relatively slow. Hot-plate procedures are limited by the boiling points of the
solutions. In addition, there can be variations between laboratories as a result of changes in atmospheric
pressure, colligative properties (convection), and conductive heating properties of conventional
apparatuses.49,50
In contrast, the use of microwave irradiation has a more direct, and thus controllable, heating mechanism
and is less susceptible to the variables mentioned previously. Microwave systems use direct absorption of
microwave radiation through essentially microwave-transparent vessel materials. Atmospheric pressure
microwave systems can generate more stable temperature conditions and are not limited by heating
mechanisms of convection or conduction.49,50
In microwave heating, energy is directly transferred to absorbing molecules in both the sample and
reagents. An examination of the role played by each of the absorption mechanisms will assist the end user
in understanding why unique conditions are achieved in microwave systems. There are two primary
microwave-absorbing mechanisms: ionic conductance and dipole rotation. In simplified terms, ionic
conductance refers to the phenomenon by which ions in solution migrate when an electromagnetic field is
applied. The solution resistance to the free flow of ions results in friction that heats the solution. This
mechanism is much less dependent on microwave frequency than is the dipole rotation mechanism.
Dipole rotation is the alignment of a molecule dipole with the applied field. Molecular “friction” results
from the very rapidly forced molecular movement caused by the oscillation of the applied field. At 2450
MHz, the dipoles align (lose entropy) and then randomize (gain entropy) 4.9 x 109 times per second,
resulting in fast, efficient, and thermodynamically predictable power absorption.49,50
©
14 Clinical and Laboratory Standards Institute. All rights reserved.
Volume 25 GP28-A
Water, methanol, and ethanol are examples of molecules likely to be used for tissue preparation.
Microwave absorption by polar reagents (charged molecules) is very high. The importance of this
information will be discussed in greater detail in Section 7.3.2.
A completely documented microwave method will enhance the likelihood for reproducible results
independent of the specific microwave unit.
©
Clinical and Laboratory Standards Institute. All rights reserved. 15
Number 7 GP28-A
Temperature control is the single most important variable in a microwave procedure. The field of
microwave sample preparation has moved toward using temperature feedback as the most widely
accepted way to gain reproducible and accurate results. However, temperature measurement in a
microwave environment is complicated by the nature of how microwave energy heats samples and by the
type of probes that can be used in a microwave device.
Insight into the complexity of measuring microwave heating of samples is provided below.
Microwave field intensity is not constant throughout the microwave cavity. Nonuniform microwave field
patterns are present in all multimode microwave cavities. These varying power densities change with
location, time, and the sample placement in the cavity. Since the variations in the field caused by
absorbing samples cannot be modeled or predicted, methods are employed to increase the homogeneity of
the field. Two such devices are the mode stirrer and the turntable or carousel that rotates the sample
through the microwave field to evenly distribute the microwave energy. Field intensity is not uniform
©
16 Clinical and Laboratory Standards Institute. All rights reserved.
Volume 25 GP28-A
within samples, because energy is absorbed primarily from the outside boundary of the load. For example,
the half-power penetration depth for a wet tissue is approximately 2 cm at 2450 MHz. At 2 cm into a wet
tissue the power will have been reduced to one half the power available in the bulk of the empty cavity.
This inherent variability of field intensity has been demonstrated in a variety of ways using an array of
neon bulbs48 (see Figure 4), thermo-sensitive paint,3 a sheet of paraffin lining the floor of the microwave
cavity,3 or infrared sensing of samples.3 Variable microwave fields are discussed further in Section
7.3.1.1. To avoid nonhomogeneous energy exposure of the samples placed in multimode microwave
cavity systems, a turntable that passes the sample through the complete microwave field is effective.
These turntables have been found to produce uniform microwave exposure of the samples and specimens,
if the turntable rotates at six revolutions per minute or greater in a nominal 1000-W microwave field. This
method of microwave field energy homogenization has become standard in laboratory chemical reaction
microwave systems.3,10,50
NOTE: Alternatively, without traversing the sample through the microwave field, the microwave heating
of relatively small samples may be controlled by measuring temperature (microwave field density
interactions) of samples placed at specific locations within the microwave device. Reproducibility
requires careful attention to consistent placement of small samples (<50 cc) in specific “charted” areas of
the microwave cavity.4,24,26,51
Figure 4. Measuring Variability of Microwave Field Intensity Using Neon Bulbs Arranged in a
Plastic Base
Materials have very different dielectric constants and hence, penetration depths of microwave energy and
consequently, heating rates (see Table 8).
NOTE: The same solution composition and sample container should be used to obtain results with lower
variability from one application to another.
The following table lists the temperature of 50 mL of several solvents after heating from room
temperature for one minute at 560 W and 2.45 GHz.47
©
Clinical and Laboratory Standards Institute. All rights reserved. 17
Number 7 GP28-A
This property is determined by the size of the sample relative to the wavelength of the microwave
energy.52 For example, small droplet volumes do not absorb microwave energy as well as larger volumes.
Also, tall samples do not absorb microwave energy as well as flat samples.
NOTE: The same container size and shape and solution volume should be used to obtain results with
lower variability from one application to another.
The heat capacity of the object determines how quickly and evenly an object heats. Water has a higher
specific heat than alcohol and therefore, requires more energy and time to heat than alcohol.
NOTE: The same solution composition should be used to obtain results with lower variability from one
application to another.
Vaporization is important with respect to small droplets typically used in histochemical procedures. The
combination of large surface area and evaporative cooling determine the rate at which a small sample
heats.
NOTE: The same volume of sample should be used to obtain results with lower variability from one
application to another.
Again, the point must be emphasized that microwave heating is not uniform within the microwave cavity
or within the samples.1,3 A single temperature measurement is rarely useful in process control. It is also
important to note that rotating tables and mode stirrers reduce but do not eliminate variability in heating
between multiple sample containers.
Many laboratory-grade microwave units have a feature in which an aerator or magnetic stirrer is used to
mix fluid during microwave heating. This approach has proven effective in minimizing temperature
variation within a single, large volume. However, the aerator does not equilibrate temperature variation
between containers located in different locations within the microwave cavity.
Currently, five types of temperature measurement devices are used commercially in laboratory
microwave systems for the direct measurement of the reaction temperature: thermocouples, fiber optics,
infrared (IR), gas-filled bulbs, and liquid crystal temperature strips (LCTS). Each of these temperature
measurement systems ideally overcomes the inherent problems and limitations of working in an
electromagnetic field.
Thermocouple measurement devices have been used for measuring temperatures for many years. In an
electromagnetic field, this measurement can occasionally lead to problems when sensors are not correctly
engineered. When thermocouples are exposed to microwaves, the microwaves couple with the
thermocouple measurement circuitry.53 Errors are produced when the metal surface interacts with the
electromagnetic field. A combination of shielding, grounding the shielding to the microwave cavity wall,
©
18 Clinical and Laboratory Standards Institute. All rights reserved.
Volume 25 GP28-A
and electroplating the thermocouple with gold either eliminates or minimizes these errors.54 The gold-
plated shielding essentially removes the thermocouple from the electromagnetic field. After calibration,
thermocouples are useful from 0 °C to 400 °C in microwave systems, and typically are accurate to
±0.1 °C.49 The cost of these devices is low.
Many microwave units have a basic thermocouple measurement device built into the unit. Inexpensive
probes are usually similar in dimension to meat probes in a domestic microwave unit. Such probes may
only have an accuracy of ±5 °C and may be difficult to place in small sample containers.49 These probes
are more likely to cause arcing and secondary heating (due to electric surface currents) of samples in
contact with the metal probe during microwave irradiation. Built-in temperature probes are designed to
monitor sample heating, but only of one sample container at a time. Stand-alone thermocouple
measurement systems can be purchased at low cost, but they can only be used to measure temperature of
samples after they have been removed from the microwave cavity.
CAUTION: Do not place any wire, such as a thermocouple, into a microwave device not specifically
permitted by the manufacturer. Without grounding the shielding to the cavity wall, microwave energy can
be transmitted along the surface of the shielding and into the laboratory.55
Fiber-optic systems are microwave transparent and nonperturbing to the microwave field. Fiber-optics
has been used in phosphorus-based and remote IR temperature sensors. Phosphorus fiber-optic sensors
use a light source outside of the microwave cavity that emits an excitation wavelength that travels through
the fiber-optic cabling to a phosphor tip.49 The measurement system converts the temperature-dependent
fluorescent decay signal into a temperature measurement by comparing the decay rate with calibration
values.56 After calibration, phosphorus fiber-optic thermometers are linear from 0 to 250 °C in microwave
systems (dependent on the specific phosphor and fiber-optic cabling). They typically have an accuracy of
±2 °C, down to ±0.2 °C with calibration near the measurement temperature. These systems can measure
multiple sample vessels at a time. The cost of these systems is very high.
Infrared (IR) temperature sensors have been used for direct and indirect temperature measurements.
Direct IR sensors use fiber optics to directly measure the solution temperature.49 Indirect IR sensors
measure the temperature of the sample vessel, usually the bottom,57 by the IR emission. The temperature
of the sample vessel may lag behind the temperature of the solution.
IR sensors may, in the future, be adapted to measure the temperature of multiple sample vessels. As the
turntable revolves, the IR sensor would measure the temperature of each vessel. If any one vessel surface
reaches the selected target temperature, the microwave power would be shut off until the temperature has
dropped below the programmed level. The cost of IR systems is typically medium to high.
Gas-filled bulb thermometers have recently been introduced.57 The measurement of temperature with
these gas-filled bulbs is based on the gas law principle; the temperature is proportional to the internal gas
pressure. After calibration, glass-bulb thermometers are linear from 0 to 250 °C and have an accuracy
between ±2 and 5 °C.49 The cost of these devices is low.
Liquid crystal temperature strips (LCTS) can measure temperature of the sample(s) or the sample
vessel(s) (depending on placement of the strip) during microwave irradiation.48 LCTS can be monitored
©
Clinical and Laboratory Standards Institute. All rights reserved. 19
Number 7 GP28-A
during irradiation by direct observation through the microwave unit window or after sample removal from
the unit cavity. LCTS typically appear black, but a bright green color becomes prominent when a
temperature specific to the reaction temperature of the particular crystal on the strip is attained. Accuracy
is within ±5 °C. There is no feedback control to the microwave device. The cost of LCTS is typically very
low, and they are reusable.
An electronic temperature probe should be accurate to ±2 °C and should be used according to the
manufacturer’s recommendations and specifications. The end user should check these instruments
periodically for accuracy.
Many microwave devices have a single shielded microwave probe. This is useful for process control
within a single container, but it is not capable of determining temperature in multiple containers.
An independent, external, electronic temperature probe should be used to determine the temperature of a
solution or sample immediately after the sample is removed from the microwave device. These
temperature measurements can be used to troubleshoot areas within the microwave device in which there
are insufficient heating or overheating of specimens (see Table 9).
NOTE: Repeating the measurement three times, and using the average reading, will provide estimates
with low uncertainty. For example, if the average temperature change were about 20 °C, experimental
data such as 19 °C, 20 °C, and 21 °C would be reasonable just from the measurement aspect (this does not
take into account any other source of uncertainty or variability).
If a microwave device is not equipped with an accurate temperature control mechanism, then the
laboratory personnel should adopt the practice of using solutions at the same starting temperatures for
every use.
The precise final temperature parameters supplied by the manufacturer or contained in published
protocols should be followed.
The temperature endpoint for tissue fixation is generally below 65 °C to prevent collagen denaturation
and sample shrinkage. Most special stains in histology are done at a temperature below 60 °C.
©
20 Clinical and Laboratory Standards Institute. All rights reserved.
Volume 25 GP28-A
Alternatively, staining and antigen retrieval procedures generally require final sample temperatures above
90 °C.
The consistency of the power output from a microwave device is directly related to the constancy of the
line voltage to the unit and the performance of the magnetron. A simple calorimetric method can be used
to determine microwave power output by the device (see Section 7.2.3).
Microwave equipment should be used on a dedicated electrical circuit. Check with the institution’s
electrical department for more information.
Magnetron output wattage is dependent on input line voltage. Variance (e.g., decreased line voltage from
the electrical utility company [brown outs]) will affect microwave power output.
Some microwave devices can be damaged if they are operated with a solution volume below their
minimum recommended by the manufacturer. This is especially important when using microwave devices
for heating microliter volumes of reagents for certain immunostaining procedures.
Other methods have been developed to smooth out nonuniform microwave field patterns.58
Measure microwave unit power output to determine if the magnetron is functioning properly. These
measurements should be performed at initial instrument set-up and quarterly thereafter.
Magnetrons and power supply ratings vary due to manufacturing tolerances by as much as 10% between
microwave units, after repair, and over the lifetime of the instrument.48
The following steps describe a method to determine the power output of a large-cavity microwave device:
(1) Place 1 L of distilled water in a 1-L narrow-mouth plastic bottle in the center of the microwave.
NOTE: A narrow-mouth bottle is used to minimize heat loss from the container.
(3) Irradiate the uncovered bottle for two minutes at 100% power.
©
Clinical and Laboratory Standards Institute. All rights reserved. 21
Number 7 GP28-A
(4) Carefully remove the bottle from the microwave device and place an appropriate cover of plastic or
foil over the mouth of the container.
(5) Invert the container or use a magnetic stirrer to mix water for five seconds immediately after
irradiation to reduce temperature variation in the heated sample.
NOTE: Perform the procedure three times to obtain sufficient readings to average.
Procedures must be reported in terms of actual microwave power, not percentages set on the microwave
unit. The following formula should be used: (change in temperature) x 35 = power in watts (35 is a
constant for converting between calories and power).
NOTE: If temperature measurement varies by more than 2 °C for a 700-W microwave device, an error of
greater than 10% can result between sample processing batches. (18 °C x 35 = 630 W; 20 °C x 35 = 700
W; 22 °C x 35 = 770 W. Mean and standard deviation of three measurements is 700 W ± 70 W. 70/700 =
10%). Since a temperature difference is measured and linearity of the thermometer within the range is a
reasonable assumption, the absolute accuracy of the thermometer is less important.49
Longer cycle times in some microwave devices do not permit smooth transitions of temperature.
Microwave devices with shorter controllable duty cycles or continuous variable power should be selected
for use.
Lack of attention to the duty cycle settings can lead to overheating samples. For example, if the duty cycle
is relatively long, at reduced power, the time that the magnetron is both on and off is longer, resulting in
possible initial overheating followed by significant heat loss causing temperature swings in the sample.3,48
Some microwave devices use continuous variable power and do not have a duty cycle. Users should
follow the manufacturer’s recommendations.
Several factors in specimen handling will determine the variability of a procedure including container
position, quantities of the solutions, and the number and types of microwave vessels.
The container location should be marked on the microwave device floor to ensure reproducible container
placement. A useful guide is an alphanumeric grid (see Figure 5) placed on the floor of the microwave
device (see Figure 6).48
©
22 Clinical and Laboratory Standards Institute. All rights reserved.
Volume 25 GP28-A
The alphanumeric grid can be made from a plastic sheet with letters written along the right and left
columns. Numbers are written along the top and bottom rows. The grid spacing is 1 cm. A large dot is
marked in the top left corner to key the alphanumeric grid to the left rear corner of the microwave cavity
(see Figures 5 and 6).
Microwave power can vary significantly within a microwave (see Figure 7). Wickersheim, et al showed a
70 °C difference in temperature within a 2-cm radius in a microwave oven56 (see Figure 8). A turntable
does not eliminate these hot and cold spots; it simply circulates the sample(s) through these areas. Some
laboratory microwave devices are designed for consistent sample placement and do not require an
alphanumeric grid (check with the microwave device manufacturer).
0 10 20 30
x/cm
Figure 8. Microwave Temperature Differences Within a 2-cm Radius. Numeric readings are
temperature, °C. (From Wickersheim K., M. Sun, and A. Kamal, 1990. A small microwave E-field probe utilizing fiberoptic
thermometry. Journal of Microwave Power and Electromagnetic Energy. 25(3):141-148. Reprinted courtesy of the International
Microwave Power Institute (Wickersheim, 1990).
The smallest container possible that the procedure will permit should be used. Do not interchange
containers with different dimensions for a given procedure. In addition, the aspect ratio of the container
used to hold the solution is important, i.e., for some given volume of solution, short, wide containers
absorb microwave energy more efficiently than tall, narrow containers.48,59
Fifty to eighty percent of microwave energy is absorbed within the first 2 cm of a solution.48,59 Therefore,
microwave heating may not be uniform throughout the volume of a solution. Some experts recommend
using rectangular containers, because cylindrical containers may focus microwave energy (e.g., similar to
a lens), resulting in sample overheating.59,60
Use microwave-transparent materials such as ceramics, sodium borosilicate glass, unleaded quartz,
fluoropolymers, and nonpolar plastics like polypropylene, polyethylene, and PTFE compounds.
Microwave-transparent materials do not absorb microwave energy and permit more uniform transmission
of power to the sample.
©
24 Clinical and Laboratory Standards Institute. All rights reserved.
Volume 25 GP28-A
When more than one container is heated in a microwave device, it is likely that the temperature will vary
from container to container.
Many experts recommend microwave units with a rotating table when heating multiple sample containers.
The rotating table should rotate at six revolutions per minute.27
Another method for determining the best placement of multiple containers for uniform heating in the
microwave cavity is by trial and error. Reproducible heating results depend on using consistent container
placement, consistent load (with respect to container size, container shape, solution volume, and solution
chemistry), and consistent bubble agitation within each container. Final irradiation temperature of each
container is measured immediately after the microwave heating cycle ends. The locations of each
container are marked on the floor of the microwave cavity with an indelible pen. This calibration should
be checked periodically or immediately after a change is made to the microwave device.
Uneven distribution of microwave fields within the microwave cavity is the primary cause for uneven
heating. Secondary causes include variation in airflow within the cavity and inconsistent agitation in the
containers.
Salt concentration, ionic conductivity, and polarity affect microwave absorption. An analytical-grade
balance should be used to measure solution components. The balance should be calibrated to at least 1%
accuracy.
Table 10 shows microwave (frequency 3 GHz) penetration depth (distance in which the intensity is
reduced in half) in various solutions typically used in clinical laboratories.
Table 10. Microwave (2.45 GHz) Penetration Depth in Various Materials (From Kok LP, Boon ME.
Microwaves for the Art of Microscopy. Fourth revised edition. Leiden: Coulomb Press Leyden; 2003. Reprinted with permission).
Medium Depth
Distilled water 25 °C 3.4 cm
0.1 M sodium chloride 2.0 cm
Ethanol 7.0 cm
Ethylene glycol 1.3 cm
Epon resin 120 cm
Paraffin wax (molten 55 °C) 150 m
The same solution should be used in all containers during a single procedure. Preparing the solution in
bulk ensures a diluent of constant composition. Solutions with different compositions absorb microwave
power differently (see Table 10).
Solution agitation during microwave irradiation improves uniformity of sample heating. Examples of
commonly used mixing methods are manual mixing by inverting the sample after it is removed from the
microwave device or bubble agitation and magnetic stirring while the sample is in the microwave device
(manufacturer dependent).
©
Clinical and Laboratory Standards Institute. All rights reserved. 25
Number 7 GP28-A
Microwave energy is introduced through a wave-guide, thereby preferentially heating one surface of the
container. Agitation prior to temperature measurement is necessary.
7.3.3 Samples
Samples with similar composition should be batch processed together. Fatty tissues (i.e., breast) and
calcified tissues do not absorb microwave energy as readily as solid organ tissues such as liver (see Table
11).3
Table 11. 2.45 GHz Microwave Penetration Depth in Biological Tissues (From Kok LP, Boon ME.
Microwaves for the Art of Microscopy. Fourth revised edition. Leiden: Coulomb Press Leyden; 2003. Reprinted with permission).
Medium Depth
Muscle and skin 2.0 cm
Fat and bone 9.0 cm
Specific procedures may require optimal positioning of the sample within its container.
Due to differences of absorption of microwave energy and shielding by some samples and reagents,
position should follow guidelines for specific applications. For example, slides placed near other slides in
a staining jar may receive less microwave energy from the field. Also, tissue samples in a fixative will
receive more microwave exposure the closer they are to the outside wall of the container.
The smallest and thinnest sample size possible should be used. Thicker specimens require longer
processing times.
All sample preparation procedures are dependent on solution penetration and chemical reactivity with the
biological sample.1,3,59 In addition, 80% of the microwave energy incident on a sample is absorbed within
the first 1 cm of the sample depth.
Many published microwave protocols will distinguish between “total time” and “time at temperature.”
Total time defines the length of time that the specimen is exposed to microwave energy. This process
includes the time it takes for the set temperature to be reached and the time the sample remains at that
temperature. Increasing the power will decrease the total processing time. Heating time may be
programmable on microwave devices by controlling power output or magnetron cycle time.
Time at temperature is defined as the amount of time the sample remains in solution that has reached a
preset incubation temperature. The time at temperature definition does not include the time needed to
heat the sample to the preselected temperature. A temperature sensor is necessary for this function.
©
26 Clinical and Laboratory Standards Institute. All rights reserved.
Volume 25 GP28-A
Multiple containers may not be maintained at the same temperature, because they are exposed to different
microwave fields in different positions within the microwave cavity. This procedure is independent of the
power setting.
The antigen retrieval (AR) technique, which is predominantly based on high-temperature heating of
tissues, is used as a nonenzymatic pretreatment for immunohistochemical staining of formalin-fixed,
paraffin-embedded tissue sections. It has been widely applied in pathology and analytical
morphology.18,22,23,60-63 (Please refer to the most current version of CLSI/NCCLS document MM4—
Quality Assurance for Immunocytochemistry for additional information.)
The use of a standardized AR protocol is recommended for all tissues that may have been over-fixed by
exposure to formalin. Variables in the AR process include the choice of retrieval solution, pH,
temperature, time, and heating method. Conventional heating in a laboratory dry-heat oven, microwave
heating, pressure-cooking, steaming, and autoclaving all may give equivalent results if temperature and
time are adjusted to optimal values. The microwave, pressure cooker, and steamer are easiest to use, but
the final choice for each laboratory may be based upon availability of equipment and convenience. Once a
heating method has been selected, each antibody procedure should be titrated to determine the optimal
staining and retrieval conditions of the corresponding antigen, for tissues processed in that laboratory. A
simple test panel (consisting of identical tissue samples) may be employed for this purpose, varying the
pH and heating time to achieve accurate, true retrieval that is traceable to optimally fixed and processed
tissue; one of the more commonly used retrieval solutions such as citrate buffer or Tris-HCl buffer with or
without 5% (w/v) urea should be used. An example of this test battery approach is shown in Table 12.23
Table 12. Test Battery for Optimal pH and Heating Using Choice Antigen Retrieval (AR) Solution
and Selected Heating Methods (Shi SR, Cote RJ, Yang C, et al. Development of an optimal protocol for antigen
retrieval: A ‘test battery’ approach exemplified with reference to the staining of retinoblastoma protein (pRB) in formalin-fixed
paraffin sections. J Pathol. Copyright© 1996. Pathological Society of Great Britain and Ireland. Reproduced with permission.
Permission is granted by John Wiley & Sons Ltd. on behalf of the Pathological Society).
Heating Condition (Temperature x Time)
pH Value of the Antigen Mid-high High Super-high
Retrieval (AR) Solution (90 °C x 10 min) (100 °C x 10 min) (>100 °C x 10 min)
Low (pH 1-2) Slide #1 Slide #4 Slide #7
Middle (pH 7-8) Slide #2 Slide #5 Slide #8
High (pH 9-10) Slide #3 Slide #6 Slide #9
The temperature of super-high at 120 °C may be reached by either autoclaving or microwave heating at a
longer time or with a microwave-safe pressure cooker.64 In contrast, the low temperature of mid-high at
90 °C may be obtained by either a water bath or a microwave monitored with an electronic temperature
probe or with LCTS. In addition to the nine slides used for this test battery, one more slide may be used
for control without AR treatment. Tris-HCl buffer solution is recommended for this test; citrate buffer of
pH 6.0 may be used to replace Tris-HCl buffer of pH 7-8, as the results are the same (see Table 12).64
©
Clinical and Laboratory Standards Institute. All rights reserved. 27
Number 7 GP28-A
Good immunohistochemical staining practice requires the use of valid positive and negative control
tissues. For a discussion on the use of controls in IHC tests, please refer to the most current edition of
CLSI/NCCLS document MM4—Quality Assurance for Immunocytochemistry.
• is a controlled process that restores (recovers) antigenicity of proteins modified (or masked) by
fixation in formalin; and
• can be used to determine that the IHC result truly detects the presence or absence of target antigen
(analyte) in the sample. If the IHC test is semiquantitative (i.e., 1, 2, 3+, or quantitative [in actual
units of measure]) the IHC result after AR should be traceable to known samples that contain the
target antigen (positive controls) and samples that lack the target antigen (negative controls).
– Examples of positive and negative tissue samples include human tumor samples that have been
analyzed with quantitative biochemical methods for the concentration of the target analyte, e.g.,
human breast cancer with biochemical analysis of estrogen and progesterone receptors; and human
tumor cell lines with quantitative biochemical, immunological, and/or nucleic acid-based analyses
(e.g., fluorescent in-situ hybridization [FISH]) of the target analyte (antigen).
– Normal human samples are excellent sources for positive and negative control samples. They may
be made into multiple tissue blocks and used as controls for all steps of the IHC testing process,
including AR procedures.
The same “test battery” approach may be used for selected, preferred heating methods or preferred AR
solutions by holding other variables (such as pH and time of heating) constant. The use of slide adhesives
is recommended. In addition, do not allow slides to dry out during microwave staining; this can lead to
artifacts in the background.
©
28 Clinical and Laboratory Standards Institute. All rights reserved.
Volume 25 GP28-A
Microwave Device
Process Time
Sample
Sample Container
Dimensions: Composition:
Number of Containers Heated at One Time:
Position of the Container Within the Cavity (alphanumeric coordinates):
Use of a Water Load and Its Volume:
Sample Immersion
©
Clinical and Laboratory Standards Institute. All rights reserved. 29
Number 7 GP28-A
10 Troubleshooting Results
The troubleshooting guide summarizes key points in this document. The information presented here can
be useful when introducing microwave procedures in the laboratory or customizing protocols for the
microwave device. The guide summarizes results, possible causes of a particular problem, and trouble-
shooting recommendations for microwave leakage, microwave fixation, microwave staining, microwave
AR, and microwave curing of embedments.
©
30 Clinical and Laboratory Standards Institute. All rights reserved.
Volume 25 GP28-A
©
Clinical and Laboratory Standards Institute. All rights reserved. 31
Number 7 GP28-A
References
1
Login GR, Dvorak AM. Methods of microwave fixation for microscopy. A review of research and clinical applications: 1970-1992. Prog
Histochem Cytochem. 1994;27(4):1-127.
2
Leong AS-Y, Milios J, Duncis CG. Antigen preservation in microwave irradiated tissues: A comparison with formaldehyde fixation. J
Pathol. 1988;156:275-282.
3
Kok LP, Boon ME. Microwaves for the Art of Microscopy. 4th ed. Leyden: Coulomb Press; 2003.
4
Giberson RT, Demaree RS. Microwave Techniques and Protocols. Totowa, NJ: Humana Press; 2001.
5
Leong AS-Y, Daymon ME, Milios J. Microwave irradiation as a form of fixation for light and electron microscopy. J Pathol.
1985;146:313-321.
6
Login GR, et al. A novel microwave device designed to preserve cell structure in milliseconds. In: Snyder WB Jr., et al, eds. Microwave
Processing of Materials II. Pittsburgh, PA: Materials Research Society; 1991.
7
Barsony J, et al. Immunocytology with microwave fixed fibroblasts shows 1-alpha, 25-dihydroxyvitamin D3 dependent rapid and estrogen
dependent slow reorganization of vitamin D receptors. J Cell Biol. 1990;111:2385-2395.
8
Mizuhira V, Notoya M, Hasegawa H. New tissue fixation method for cytochemistry using microwave irradiation I. General remarks. Acta
Histochem Cytochem. 1990;18:501-523.
9
Medina MA, Deam AP, Stavinoha WB. Inactivation of brain tissue by microwave irradiation. In: Passonneau JV, et al, eds. Cerebral
Metabolism and Neural Function. New York, NY: Williams and Wilkins; 1980.
10
Kingston HMS, Haswell SJ, eds. Microwave-Enhanced Chemistry. Fundamentals, Sample Preparation, and Applications. Washington,
D.C.: American Chemical Society; 1997.
11
Mori T, et al. Improved power control during microwave heating in biological applications. Dent Mater J. 1992;11(2):197-203.
12
Barsony J, Marx SJ. Immunocytology on microwave-fixed cells reveals rapid and agonist-specific changes in subcellular accumulation
patterns for cAMP or cGMP. Proc Natl Acad Sci. 1990;87:1188-1192.
13
Boon ME, et al. The two-step vacuum-microwave method for histoprocessing. Eur J Morphol. 1995;33(4):349-358.
14
Kok LP, Boon ME. Ultrarapid vacuum-microwave histoprocessing. Histochem J. 1995;27(5):411-419.
15
Visinoni F, et al. Ultra-rapid microwave/variable pressure-induced histoprocessing. Description of a new tissue processor. J Histotechnol.
1998;21:219-224.
16
Yasuda K, et al. Application of ultrasound for tissue fixation: Combined use with microwave to enhance the effect of chemical fixation.
Acta Histochem Cytochem. 1992;25:237-244.
17
Leong AS, Sormunen RT. Microwave procedures for electron microscopy and resin-embedded sections. Micron. 1998;29(5):397-409.
18
Leong AS. International Lecture: Applications of Microwaves in Immunohistology. In: National Society for Histotechnology 23rd Annual
Symposium. Columbus, OH; 1997.
19
Leong AS. Microwaves in diagnostic immunohistochemistry. Eur J Morphol. 1996;34(5):381-383.
20
Leong AS-Y. Microwave fixation and rapid processing in a large throughput histopathology laboratory. Pathol. 1991;23:271-273.
21
Kok LP. Fundamentals of microwave-stimulated staining. In: Boon ME, Kok LP, eds. Standardization and Quantitation of Diagnostic
Staining in Cytology. Leyden: Coulomb Press; 1986.
22
Shi SR, Cote RJ, Taylor CR. Antigen retrieval techniques: Current perspectives. J Histochem Cytochem. 2001;49(8):931-937.
23
Shi SR, Cote RJ, Taylor CR. Antigen retrieval immunohistochemistry: Past, present, and future. J Histochem Cytochem. 1997;45(3):327-
343.
24
Login GR, Leonard JB, Dvorak AM. Calibration and standardization of microwave ovens for fixation of brain and peripheral nerve tissue.
Companion to Methods Enzymol. 1998;15(2):107-117.
25
Login GR, Tanda N, Dvorak AM. Calibrating and standardizing microwave ovens for microwave-accelerated specimen preparation. A
review. Cell Vision. 1996; 3(3):172-179.
26
Giberson RT, Demaree RS Jr. Microwave fixation: Understanding the variables to achieve rapid reproducible results. Microsc Res Tech.
1995;32:246-254.
©
32 Clinical and Laboratory Standards Institute. All rights reserved.
Volume 25 GP28-A
27
Kingston HM, et al. Laboratory microwave safety. In: Kingston HMS, Haswell SJ, eds. Microwave-Enhanced Chemistry. Fundamentals,
Sample Preparation, and Applications. Washington, D.C.: American Chemical Society; 1997.
28
ISO. International Vocabulary of Basic and General Terms in Metrology. Geneva: International Organization for Standardization; 1993.
29
ISO. Accuracy (trueness and precision) of measurement methods and results – Part 1: General principles and definitions. ISO 5725-1.
Geneva: International Organization for Standardization; 1994.
30
ISO. Medical laboratories– Particular requirements for quality and competence. ISO 15189. Geneva: International Organization for
Standardization; 2003.
31
CDC. Guidelines for Protecting the Safety and Health of Healthcare Workers. Cincinnati, OH. U.S. Department of Health and Human
Services; 1988.
32
Center for Microwave and Analytical Chemistry (C/MAC) SamplePrep Web™ at Duquesne University.
www.sampleprep.duq.edu/sampleprep.
33
OSHA. Nonionizing Radiation. 29 CFR §1919.97. U.S. Government Printing Office: Washington, D.C.; 2002.
34
CDRH. Food and Drugs: Records and Reports: Records to be Maintained by Manufacturers. 21 CFR §1002.30. U.S. Food and Drug
Administration.
35
CDRH. Food and Drugs: Notification of Defects or Failure to Comply. 21 CFR §1003. U.S. Food and Drug Administration; 2002.
36
CDRH. Food and Drugs: Repurchase, Repairs, or Replacement of Electronic Products. 21 CFR §1004. U.S. Food and Drug
Administration; 2002.
37
Thuery J. Microwave: Industrial, Scientific and Medical Applications. Norwood, MA: Artech House; 1992.
38
FDA. Performance Standards for Microwave and Radio Frequency Emitting Products. Microwave Ovens. 21 CFR §1030. U.S.
Government Printing Office: Washington, D.C.; 2002.
39
Federal Food, Drug, and Cosmetic Act: Section 201(h). 21 USC 321.
40
CDRH. Food and Drugs: Abbreviated Reports. 21 CFR §1002.12. U.S. Food and Drug Administration; 2002.
41
CDRH. Good Manufacturing Practice for Medical Devices. 21 CFR §820. U.S. Food and Drug Administration; 2002.
42
Kingston HM, Jassie LB. Safety guidelines for microwave systems in the analytical laboratory period. In: Kingston HM, Jassie LB, eds.
Introduction to Microwave Sample Preparation: Theory and Practice. Washington, D.C.: American Chemical Society; 1988.
43
Mudgett RE. Developments in microwave food processing. In: Schwartzberg HG, Rao M, eds. Biotechnology and Food Process
Engineering. New York, NY: Marcel Dekker, Inc.; 1990.
44
CDRH. Performance Standards for Microwave and Radio Frequency Emitting Products. 21 CFR §1030.12. U.S. Food and Drug
Administration; 2002.
45
American Industrial Hygiene Association. American National Standard for Laboratory Ventilation. ANSI/AIHAZ9.5-1992.
46
American Industrial Hygiene Association. American National Standard for the Recirculation of Air from Industrial Process Exhaust
Systems. ANSI/AIHA Z9.7-1998.
47
Mingos DMP, Baghurst DR. Applications of microwave dielectric heating effects to synthetic problems in chemistry. In: Kingston HMS,
Haswell SJ, eds. Microwave-Enhanced Chemistry. Fundamentals, Sample Preparation, and Applications. Washington, D.C.: American
Chemical Society; 1997.
48
Login GR, Dvorak AM. The Microwave Toolbook. A Practical Guide for Microscopists. Boston, MA: Beth Israel Hospital; 1994.
49
Kingston HMS, et al. Environmental microwave sample preparation: Fundamentals, methods, and applications. In: Kingston HMS, Haswell
SJ, eds. Microwave-Enhanced Chemistry. Fundamentals, Sample Preparation, and Applications. Washington, D.C.: American Chemical
Society; 1997:223-349.
50
Neas ED, Collins MJ. Microwave heating: Theoretical concepts and equipment. In: Kingston HM, Jassie LB, eds. Introduction to
Microwave Sample Preparation: Theory and Practice. Washington, D.C.: American Chemical Society; 1988:7-32.
51
Jensen FE, Harris KM. Preservation of neuronal ultrastructure in hippocampal slices using rapid microwave-enhanced fixation. J Neurosci
Methods. 1989;29:217-230.
52
Choi TS, et al. Advances in temperature control of microwave immunohistochemistry. Cell Vision. 1995;2(2):151-164.
53
Chakraborty DP, Brezovich IA. Error sources affecting thermocouple thermometry in RF electromagnetic fields. J Microw Power.
1982;17(1):17-28.
©
Clinical and Laboratory Standards Institute. All rights reserved. 33
Number 7 GP28-A
54
Kingston HM, Jassie LB, eds. Introduction to Microwave Sample Preparation Theory and Practice. American Chemical Society:
Washington, D.C.; 1988:(6)93-154.
55
Kingston HM, Jassie LB. Microwave energy for acid decomposition at elevated temperatures and pressures using biological and botanical
samples. Anal Chem. 1986;58:2534-2541.
56
Wickersheim KA, Sun MH, Kamal A. A small microwave E-field probe utilizing fiberoptic thermometry. J Microwave Power.
1990;25(3):141-148.
57
Lorentzen EM, Kingston HM. The advantage feedback controlled microwave assisted leaching under atmospheric pressure. In: Total
Microwave Processing Using Microwave Technologies. Federation of Analytical Chemistry and Spectroscopy Societies: Cincinnati, OH;
1995.
58
Giberson RT, Austin RL, Charlesworth J, Adamson G, Herrera GA. Microwave and digital imaging technology reduce turnaround times for
diagnostic electron microscopy. Ultrastruct Pathol. 2003;27(3):187-196.
59
Kok LP, Boon ME. Physics of microwave technology in histochemistry. Histochem J. 1990;22:381-388.
60
Cattoretti G, Suurmeijer A. Antigen unmasking on formalin-fixed paraffin-embedded tissues using microwaves: A review. Adv Anat Path.
1995;2:2-9.
61
Shi SR, Key ME, Kalra KL. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: An enhancement method for
immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem. 1991;39(6):741-748.
62
Shi SR, Cote RJ, Taylor RC. Antigen retrieval immunohistochemistry and molecular morphology in the year 2001. Appl Immunohistochem
Molecul Morphol. 2001;9(2):107-116.
63
Leong AS, Milios J. An assessment of the efficacy of the microwave antigen-retrieval procedure on a range of tissue antigens. Appl
Immunohistochem. 1993;1(4):267-274.
64
Shi SR, Cote RJ, Yang C, et al. Development of an optimal protocol for antigen retrieval: A ‘test battery’ approach exemplified with
reference to the staining of retinoblastoma protein (pRB) in formalin-fixed paraffin sections. J Pathol. 1996;179(3):347-352.
65
Giammara BL, Birch DJ, Harper DO. Microwave polymerization of embedding resins for biological/biomedical electron microscopy. In:
Snyder WB, et al, eds. Microwave Processing of Materials II. Pittsburgh, PA: Materials Research Society; 1991:347-353.
66
Giammara B. Microwave embedment for light and electron microscopy using epoxy resins, LR White, and other polymers. Scanning.
1993;15:82-87.
©
34 Clinical and Laboratory Standards Institute. All rights reserved.
Volume 25 GP28-A
Clinical and Laboratory Standards Institute consensus procedures include an appeals process that
is described in detail in Section 8 of the Administrative Procedures. For further information,
contact the Executive Offices or visit our website at www.clsi.org.
General
1. The document should include microwave technology utilization in the blood bank.
2. Include comprehensive discussion(s) specific to the domestic microwave user. It should identify which procedures may be
suitable for domestic units (outside of regulatory limitations) in more detail than simply listing them in Table 2 and
specifically how those methodologies may be carried out. Expound on the benefits of laboratory-grade microwave devices
for certain applications, explaining why they are advantageous to the user in those specific instances.
• The document is a guideline regarding microwave device safety and reproducibility. The guideline reports well-
documented general principles that laboratory technicians can apply to any published protocol in any microwave
device with an oven-like interior with the goal of improving reproducibility. This information is contained in Section
7, Critical Descriptors for Microwave-Accelerated Procedures and Section 10, Troubleshooting Results.
The document purposely does not describe specific methods, because these are already published in textbooks such
as Kok LP, Boon ME. Microwaves for the Art of Microscopy. Leyden: Coulomb Press; 2003 and Giberson RT,
Demaree RS. Microwave Techniques and Protocols. Totowa, NJ: Humana Press; 2001.
Table 2 in the guideline refers to basic and advanced functionality of FDA- and OSHA-compliant microwave devices.
The subcommittee thought it was important for laboratory technicians to also know this information, so they can
make informed purchasing decisions depending on their intended applications.
3. Include a discussion of the limitations of domestic microwave devices and which methodologies are unsuitable for this type
of device and why. This information will allow those considering the purchase of microwave technology to make informed
decisions appropriate for the procedures they intend to perform.
• This guideline is the first publication to collate, document, and discuss the limitations of domestic microwave ovens in
a hospital laboratory. Domestic microwave appliances do not meet FDA and OSHA guidelines for use in a hospital
laboratory environment. Please refer to Section 4.2, Electrical Precautions.
4. Offer domestic microwave device users strategies to enable them to achieve reproducible results.
• This information is outlined in Section 7, Critical Descriptors for Microwave-Accelerated Procedures and Section 10,
Troubleshooting Results.
5. This guideline calls it “immunohistochemistry” and uses the abbreviation IHC. The NCCLS document MM4-A uses the
word “immunocytochemistry” throughout. Though both are interchangeable, and though most histotechs seem to use the
term “immunohistochemistry” or “IHC,” NCCLS should consider sticking with one of the terminologies for consistency.
• “Histo” refers to tissue seen at the light microscopy magnification, and “cyto” refers to cells seen at electron
microscope magnification. The term “immunohistochemistry” is more accurate in this document.
6. When written after a number, either use the word for a measurement (i.e., 400 Watts), or use the symbol (400 W) throughout
the document. This is varied throughout the document.
• The symbol for a watts measurement (W) has been made consistent throughout the document.
©
Clinical and Laboratory Standards Institute. All rights reserved. 35
Number 7 GP28-A
Section 2, Introduction
7. On page 1, last sentence, I would like to see this sentence rewritten to state, “Household microwave units are designed for
food preparation, and they are not certified for laboratory use; however, many laboratories have used them (effectively) for
staining, heating agar, heat activated epitope retrieval, and drying slides, (as long as proper safety precautions are
followed.)”
I think the average laboratorian trying to read this document will not understand what “Subpart S” or “Chapter V Subchapter
A-Drug & Devices”; or 29CFR 1910 means. I think for the purposes of a user-friendly document, this sentence should be
added in the text.
• The subcommittee acknowledges that domestic microwave ovens have been a cost-effective and successful piece of
equipment for many procedures in the laboratory. Their continued use is subject to the discretion of the individual
laboratory and hospital administrators. However, since domestic microwave ovens unequivocally do not meet the
electrical safety requirements of the FDA and OSHA for hospital laboratories, mention of domestic microwave oven
use has been eliminated from this guideline.
This guideline is written for multiple audiences including laboratory technicians, microwave device manufacturers,
microwave device resellers, compliance and safety officials, and administrators. Section 4.2, Electrical Precautions,
is relevant to technicians who want to know what is necessary to make a domestic appliance compliant with FDA
regulations for hospital laboratory use.
Section 3, Definitions
8. “Arcing” referred to relatively frequently in the text. Define “arc” and any implications with fire hazard.
9. The majority of histology professionals in the United States are histologic technicians (HT) with a high school diploma
and trained on the job. For most of these individuals, a background in the theory of chemistry and physics is minimal to
nonexistent. Most HT with associate degrees, and the histotechnologists (HTL) with baccalaureate degrees, have not taken
physics in high school or college. Therefore, their background knowledge of microwave radiation and electricity is
minimal, at best.
It would be to the advantage of these readers to include more definitions in the front of the booklet, including units of
measure.
Hertz - include the symbol Hz. Include a brief definition of MHz and GHz. (page 3)
Inductance (page 3)
Diode (page 3)
Anode (page 3)
Cathode (page 3)
Arcing (page 7)
©
36 Clinical and Laboratory Standards Institute. All rights reserved.
Volume 25 GP28-A
• The definitions for the above terms have been added as suggested with the exception of “incident wave.” The term
“incident wave” has been replaced with “microwave frequency” (page 14).
10. I believe that the safety sections of the document should be modified and enhanced to increase their value to the reader.
There seems to be an overwhelming emphasis in some of these sections on how domestic units violate various regulatory
standards which are in some cases difficult to follow. I believe that this document should provide useful information
pointing the reader to standards that may apply rather than attempting to interpret the standards in a lengthy discussion that
may lose the reader. Ultimately compliance is up to the user. My suggestions are listed below:
a. It is puzzling that Section 4.1.1 (Microwave Radiation Safety) appears more concerned with FDA regulations than
microwave radiation safety. It never identifies the most basic hazard posed to individuals with pacemakers. I do not believe
that the paragraph at the top of page 5 will be useful to the reader. This section is supposed to be about microwave radiation
safety yet seems to be focused on the issue of “heating, cooking or drying food….and is manufactured for use in homes,
restaurants, food vending or service establishments.” I see no relevance of these remarks to radiation safety concerns unless
it can be demonstrated that domestic microwave devices pose a greater radiation hazard than other types of devices.
• Section 4.1.1 states that all microwave devices must comply with FDA regulations of microwave leakage. The
subcommittee did not find documentation about radiation hazards specific to domestic microwave devices, so this
was not raised as a concern in the guideline. The FDA DOES require that a microwave device be used solely for the
purpose for which it was designed, and this statement is reported in the guideline.
At one time there was concern that leakage from microwave ovens could interfere with certain electronic cardiac
pacemakers. There was similar concern about pacemaker interference from electric shavers, auto ignition systems,
and other electronic products. Because there are so many other products that also could cause this problem, FDA
does not require microwave ovens to carry warnings for people with pacemakers. The problem has been largely
resolved, since pacemakers are now designed so they are shielded against such electrical interference. However,
patients with pacemakers may wish to consult their physicians about this (refer to Section 4 for further details).
b. In Section 4.1.2, the first paragraph appears to have no relevance to the title of this section and will be confusing to the
reader as it discusses “if the equipment is modified or integrity of the safety device is violated...” I have no idea what this
has to do with classifying microwave equipment as medical devices. It appears to me that the content of Table 3 contains
more useful information for the reader than the attempts in the text to interpret the regulations which are confusing and
unclear. Likewise, the last paragraph on page 5 is equally confusing to the reader. Few practitioners will find the statement
“If a manufacturer or user modifies a household microwave oven or commercially promotes histological use as an indication
for use…” relevant to their circumstances. They may utilize a domestic device but are they “commercially” promoting
histological use? In my opinion this section needs a major overhaul. It would seem to me that its intent could be summed
up with a simple statement such as the following:
“Those who use microwave devices for other than that intended by the manufacturer must comply with standards of the
Occupational Safety and Health Administration and the FDA.” The section can then point the reader to the specific
regulations. I can't stress enough that clarity is key to reaching the reader.
• This guideline is written for multiple audiences including laboratory technicians, microwave device manufacturers,
microwave device resellers, compliance and safety officials, and administrators.
Section 4.2 is relevant to technicians who want to know what is necessary to make a domestic appliance compliant
with FDA regulations for hospital laboratory use. This section is also necessary for microwave resellers to be aware
that they cannot put their private label on a domestic microwave oven and promote it as a laboratory device. This
type of device violates FDA regulations as noted in Table 3. The subcommittee thought it was important for
laboratory technicians to also know this information so that they can make informed purchasing decisions.
Additional text has been added as introductory sentences in Section 4.1.3 to clarify this section as follows: “This
section provides regulatory information primarily for microwave device manufacturers, microwave device resellers,
compliance and safety officials, and administrators. The information below may also assist laboratory technicians
making purchasing decisions of microwave devices that are in compliance FDA and OSHA regulations.”
c. In Section 4.2, I find the second and third paragraphs of this section confusing. It appears to be saying that domestic
microwave devices and laboratory-grade devices are covered by different UL standards and that the UL standard for
domestic devices does not cover laboratory applications. Couldn't this section’s message be stated more clearly and
©
Clinical and Laboratory Standards Institute. All rights reserved. 37
Number 7 GP28-A
succinctly as I’ve stated it here? My interpretation of this section is that domestic ovens are not tested according to UL
61010A-1, not that they were tested and failed to pass this electrical certification. It seems to me that the first paragraph
covers the relevant points. The other commentary is difficult to follow and will likely lose the reader.
• The three paragraphs in Section 4.2 actually describe three independent criteria for electrical safety. Paragraph one
outlines that specific electrical safety codes can only be tested by recognized national testing agencies; e.g., recognized
by OSHA (USA), CSA (Canada); or authorized to affix the mark (European States). Paragraph two states
domestic microwave devices are not designed or tested to meet the more stringent door seal and endurance tests
required in 61010A-1. Paragraph three informs the reader that the electrical safety code UL 923 is for domestic
microwave ovens, and because their electrical system is not shielded from the microwave cavity they must not be
used with caustic or corrosive vapors. Manufacturers are required to state in their instructions that household ovens
are only for heating food.
Additional text has been added as introductory sentences in Section 4.2 to clarify this section as follows: “This section
provides electrical safety information primarily for microwave device manufacturers, microwave device resellers,
compliance and safety officials, and administrators. Laboratory technicians are advised that according to OSHA
household microwave ovens do not meet the more stringent door seal and endurance tests required for applications
outside the home.”
11. The first sentence of the second paragraph in Section 4.3, Biological Precautions, suggests that some pathogens are
destroyed by microwave heating, but it never tells the reader which ones are and which ones are not. This statement refers to
a publication that is ten years old. If more current studies do not exist or if the committee is not comfortable identifying
which pathogens are neutralized by microwave heating, why not simply state “the utility of using microwave energy to
destroy pathogens requires further study” followed by “all potentially infectious specimens must be handled with standard
precautions during and after the use of microwave irradiation.” In the absence of definitive information, the first sentence
becomes misleading as if to say, “Microwave irradiation may destroy your pathogen, or it may not!”
12. Section 4.4., Chemical Handling Precautions, is a good start but I feel that it should be substantially expanded. What
chemicals should absolutely not be used in a microwave device? Are there any that might explode or ignite? I feel strongly
that this section needs to be much more informative and should even contain a comprehensive listing of chemicals
commonly utilized in histology laboratories and any special precautions for microwave applications.
13. The last sentence in Section 4.5, High Temperature Precautions, states: “The risk of spontaneous boil over in histopathology
applications is more likely during microwave staining and heat-induced epitope retrieval.” More likely than what? If this
statement is correct, why is this so? Is this possible result limited to a particular type of microwave device and if not, what
can be done to reduce the likelihood of such an outcome? I believe that the reader will want to know if this can be explained
in greater detail.
• The sentence has been modified to state, “…more likely during high temperature heating procedures, such as...”
The explanations provided in the literature for microwave-induced boil over are super heating and bubble nucleation
(refer to cited references 27 and 43). Since there is no method provided in the literature to prevent spontaneous boil
over, technicians should use protective thermal gloves when removing solutions heated to near boiling.
14. With the word accuracy, can we add the symbol “±.” Such as,
©
38 Clinical and Laboratory Standards Institute. All rights reserved.
Volume 25 GP28-A
16. This section starts out with “IR Temperature Sensors,” and the reader has to go to the top of the page to find the definition of
“IR.” Page 17 — 7.1.2.5 starts out with “Liquid Crystal Temperature Strips,” and then abbreviated it in the first sentence to
LCTS. The mode on page 17 appears for the LCTS seems clearer.
• The abbreviation “IR” has been spelled out in the title of this section as suggested.
17. Second paragraph: Does staining really require the final sample temperature to be above 90 °C?
• Most special stains in histology are done at a temperature range of 22 to 60 °C. Text has been added to reflect this.
18. #4 — "... place an appropriate cover of plastic or foil." The question is where? Over the mouth of the bottle? Around the
outside of the container?
• There is no consensus about container shape within the subcommittee; however, the recommendation for rectangular
containers is based on cited literature (see cited references 59 and 60).
20. This section alternates between heat-induced epitope retrieval (without indicating the HIER abbreviation) and AR (without
defining AR as antigen recovery or antigen retrieval. Suggest using HIER consistently, with the abbreviation.
• The term “heat-induced epitope retrieval” has been replaced with “antigen retrieval” (AR) throughout this section.
Table 13
21. “Microwave Curing — Results — Mold Deforms” — Before the word “mold,” insert “Embedding.” Mold, in histology,
can also mean “fungus.”
©
Clinical and Laboratory Standards Institute. All rights reserved. 39
Number 7 GP28-A
GP28-A addresses the quality system essentials (QSEs) indicated by an “X.” For a description of the other
CLSI/NCCLS documents listed in the grid, please refer to the Related CLSI/NCCLS Publications section on the
following page.
Purchasing &
Improvement
Organization
Management
Management
Information
Satisfaction
Assessment
Facilities &
Occurrence
Documents
Equipment
& Records
Service &
Personnel
Inventory
Control
Process
Process
Safety
X
Adapted from CLSI/NCCLS document HS1—A Quality Management System Model for Health Care.
©
40 Clinical and Laboratory Standards Institute. All rights reserved.
Volume 25 GP28-A
MM4-A Quality Assurance for Immunocytochemistry; Approved Guideline (1999). This document provides
recommendations for the performance of immunocytochemical assays on cytologic and surgical pathology
specimens. It is intended to promote a better understanding of the requirements, capabilities, and limitations of
these diagnostic methods; to improve their intra- and interlaboratory reproducibility; and to improve their
positive and negative predictive values in the diagnosis of disease.
*
Proposed- and tentative-level documents are being advanced through the Clinical and Laboratory Standards Institute consensus
process; therefore, readers should refer to the most recent editions.
©
Clinical and Laboratory Standards Institute. All rights reserved. 41
Number 7 GP28-A
NOTES
©
42 Clinical and Laboratory Standards Institute. All rights reserved.
Volume 25 GP28-A
NOTES
©
Clinical and Laboratory Standards Institute. All rights reserved. 43
Number 7 GP28-A
NOTES
©
44 Clinical and Laboratory Standards Institute. All rights reserved.
Volume 25 GP28-A
NOTES
©
Clinical and Laboratory Standards Institute. All rights reserved. 45
Number 7 GP28-A
NOTES
©
46 Clinical and Laboratory Standards Institute. All rights reserved.
Volume 25 GP28-A
NOTES
©
Clinical and Laboratory Standards Institute. All rights reserved. 47
Active Membership
(as of 1 January 2005)
Sustaining Members Chinese Committee for Clinical F. Hoffman-La Roche AG Aurora Consolidated Laboratories
Laboratory Standards Fort Dodge Animal Health (WI)
Abbott Laboratories Commonwealth of Pennsylvania Gen-Probe AZ Sint-Jan (Belgium)
American Association for Clinical Bureau of Laboratories GenVault Azienda Ospedale Di Lecco (Italy)
Chemistry Department of Veterans Affairs GlaxoSmithKline Barnes-Jewish Hospital (MO)
Bayer Corporation Deutsches Institut für Normung Greiner Bio-One Inc. Baxter Regional Medical Center
BD (DIN) Immunicon Corporation (AR)
Beckman Coulter, Inc. FDA Center for Devices and ImmunoSite, Inc. Baystate Medical Center (MA)
bioMérieux, Inc. Radiological Health Instrumentation Laboratory Bbaguas Duzen Laboratories
CLMA FDA Center for Veterinary Medicine International Technidyne (Turkey)
College of American Pathologists FDA Division of Anti-Infective Corporation BC Biomedical Laboratories (Surrey,
GlaxoSmithKline Drug Products I-STAT Corporation BC, Canada)
Ortho-Clinical Diagnostics, Inc. Iowa State Hygienic Laboratory Johnson and Johnson Pharmaceutical Bermuda Hospitals Board
Pfizer Inc Massachusetts Department of Public Research and Development, L.L.C. Bo Ali Hospital (Iran)
Roche Diagnostics, Inc. Health Laboratories K.C.J. Enterprises Bon Secours Hospital (Ireland)
National Center of Infectious and LifeScan, Inc. (a Johnson & Johnson Brazosport Memorial Hospital (TX)
Professional Members Parasitic Diseases (Bulgaria) Company) Broward General Medical Center
National Health Laboratory Service Machaon Diagnostics (FL)
American Academy of Family (South Africa) Medical Device Consultants, Inc. Cadham Provincial Laboratory
Physicians National Institute of Standards and Merck & Company, Inc. (Winnipeg, MB, Canada)
American Association for Clinical Technology Micromyx, LLC Calgary Laboratory Services
Chemistry National Pathology Accreditation Minigrip/Zip-Pak (Calgary, AB, Canada)
American Association for Advisory Council (Australia) Nanosphere, Inc. California Pacific Medical Center
Respiratory Care New York State Department of National Pathology Accreditation Canterbury Health Laboratories
American Chemical Society Health Advisory Council (Australia) (New Zealand)
American Medical Technologists Ontario Ministry of Health Nippon Becton Dickinson Co., Ltd. Cape Breton Healthcare Complex
American Society for Clinical Pennsylvania Dept. of Health Nissui Pharmaceutical Co., Ltd. (Nova Scotia, Canada)
Laboratory Science Saskatchewan Health-Provincial Norfolk Associates, Inc. Carilion Consolidated Laboratory
American Society for Microbiology Laboratory Novartis Pharmaceuticals (VA)
American Society of Hematology Scientific Institute of Public Health; Corporation Carolinas Medical Center (NC)
American Type Culture Collection, Belgium Ministry of Social Olympus America, Inc. Cathay General Hospital (Taiwan)
Inc. Affairs, Public Health and the Optimer Pharmaceuticals, Inc. Central Texas Veterans Health Care
Asociacion Mexicana de Bioquimica Environment Ortho-Clinical Diagnostics, Inc. System
Clinica A.C. Swedish Institute for Infectious (Rochester, NY) Centro Diagnostico Italiano (Milano,
Assn. of Public Health Laboratories Disease Control Ortho-McNeil Pharmaceutical Italy)
Assoc. Micro. Clinici Italiani- (Raritan, NJ) Chang Gung Memorial Hospital
A.M.C.L.I. Industry Members Oxoid Inc. (Taiwan)
British Society for Antimicrobial Paratek Pharmaceuticals Changi General Hospital
Chemotherapy AB Biodisk Pfizer Animal Health (Singapore)
Canadian Society for Medical Abbott Laboratories Pfizer Inc Children’s Hospital (NE)
Laboratory Science - Société Abbott Diabetes Care Pfizer Italia Srl Children’s Hospital & Clinics (MN)
Canadienne de Science de Acrometrix Corporation Powers Consulting Services Children’s Hospital Medical Center
Laboratoire Médical Advancis Pharmaceutical Procter & Gamble Pharmaceuticals, (Akron, OH)
Canadian Standards Association Corporation Inc. Children’s Medical Center of Dallas
Clinical Laboratory Management Affymetrix, Inc. QSE Consulting (TX)
Association Ammirati Regulatory Consulting Radiometer America, Inc. Chinese Association of Advanced
COLA Anna Longwell, PC Radiometer Medical A/S Blood Bankers (Beijing)
College of American Pathologists A/S ROSCO Replidyne CHR St. Joseph Warquignies
College of Medical Laboratory AstraZeneca Pharmaceuticals Roche Diagnostics GmbH (Belgium)
Technologists of Ontario Aventis Roche Diagnostics, Inc. City of Hope National Medical
College of Physicians and Surgeons Axis-Shield POC AS Roche Laboratories (Div. Hoffmann- Center (CA)
of Saskatchewan Bayer Corporation - Elkhart, IN La Roche Inc.) Clarian Health - Methodist Hospital
ESCMID Bayer Corporation - Tarrytown, NY Sarstedt, Inc. (IN)
International Council for Bayer Corporation - West Haven, Schering Corporation CLSI Laboratories (PA)
Standardization in Haematology CT Schleicher & Schuell, Inc. Community Hospital of Lancaster
International Federation of BD Second Opinion (PA)
Biomedical Laboratory Science BD Consumer Products SFBC Anapharm Community Hospital of the
International Federation of Clinical BD Diagnostic Systems Streck Laboratories, Inc. Monterey Peninsula (CA)
Chemistry BD VACUTAINER Systems SYN X Pharma Inc. CompuNet Clinical Laboratories
Italian Society of Clinical Beckman Coulter, Inc. Sysmex Corporation (Japan) (OH)
Biochemistry and Clinical Beckman Coulter K.K. (Japan) Sysmex Corporation (Long Grove, Cook County Hospital (IL)
Molecular Biology Bio-Development SRL IL) Covance Central Laboratory
Japan Society of Clinical Chemistry Bio-Inova Life Sciences TheraDoc Services (IN)
Japanese Committee for Clinical International Theravance Inc. Creighton University Medical Center
Laboratory Standards Biomedia Laboratories SDN BHD Thrombodyne, Inc. (NE)
Joint Commission on Accreditation bioMérieux, Inc. (MO) THYMED GmbH Danish Veterinary Laboratory
of Healthcare Organizations Biometrology Consultants Transasia Engineers (Denmark)
National Academy of Clinical Bio-Rad Laboratories, Inc. Trek Diagnostic Systems, Inc. Detroit Health Department (MI)
Biochemistry Bio-Rad Laboratories, Inc. – France Vetoquinol S.A. DFS/CLIA Certification (NC)
National Association of Testing Bio-Rad Laboratories, Inc. – Plano, Vicuron Pharmaceuticals Inc. Diagnósticos da América S/A
Authorities - Australia TX Vysis, Inc. (Brazil)
National Society for Blaine Healthcare Associates, Inc. Wyeth Research Dr. Everett Chalmers Hospital (New
Histotechnology, Inc. Bristol-Myers Squibb Company XDX, Inc. Brunswick, Canada)
New Zealand Association of Canadian External Quality YD Consultant Duke University Medical Center
Phlebotomy Assessment Laboratory YD Diagnostics (Seoul, Korea) (NC)
Ontario Medical Association Quality Cepheid Dwight David Eisenhower Army
Management Program-Laboratory Chen & Chen, LLC Trade Associations Medical Center (GA)
Service Chiron Corporation Eastern Health Pathology (Australia)
RCPA Quality Assurance Programs ChromaVision Medical Systems, AdvaMed Emory University Hospital (GA)
PTY Limited Inc. Japan Association of Clinical Enzo Clinical Labs (NY)
Sociedad Espanola de Bioquimica Clinical Micro Sensors Reagents Industries (Tokyo, Japan) Evangelical Community Hospital
Clinica y Patologia Molecular The Clinical Microbiology Institute (PA)
Sociedade Brasileira de Analises Cognigen Associate Active Members Fairview-University Medical Center
Clinicas CONOSCO (MN)
Taiwanese Committee for Clinical Copan Diagnostics Inc. 82 MDG/SGSCL (Sheppard AFB, Florida Hospital East Orlando
Laboratory Standards (TCCLS) Cosmetic Ingredient Review TX) Focus Technologies (CA)
Turkish Society of Microbiology Cubist Pharmaceuticals Academisch Ziekenhuis -VUB Focus Technologies (VA)
Dade Behring Inc. - Cupertino, CA (Belgium) Foothills Hospital (Calgary, AB,
Government Members Dade Behring Inc. - Deerfield, IL Alfred I. duPont Hospital for Canada)
Dade Behring Inc. - Glasgow, DE Children (DE) Franciscan Shared Laboratory (WI)
Armed Forces Institute of Pathology Dade Behring Inc. - Marburg, All Children’s Hospital (FL) Fresno Community Hospital and
Association of Public Health Germany Allegheny General Hospital (PA) Medical Center
Laboratories Dade Behring Inc. - Sacramento, CA Allina Health System (MN) Gamma Dynacare Medical
BC Centre for Disease Control David G. Rhoads Associates, Inc. American University of Beirut Laboratories (Ontario, Canada)
Caribbean Epidemiology Centre Diagnostic Products Corporation Medical Center (NY) Gateway Medical Center (TN)
Centers for Disease Control and Digene Corporation Anne Arundel Medical Center (MD) Geisinger Medical Center (PA)
Prevention Eiken Chemical Company, Ltd. Antwerp University Hospital Guthrie Clinic Laboratories (PA)
Centers for Medicare & Medicaid Elanco Animal Health (Belgium) Hagerstown Medical Laboratory
Services Electa Lab s.r.l. Arkansas Department of Health (MD)
Centers for Medicare & Medicaid Enterprise Analysis Corporation ARUP at University Hospital (UT) Harris Methodist Fort Worth (TX)
Services/CLIA Program Associated Regional & University Hartford Hospital (CT)
Pathologists (UT) Headwaters Health Authority
Atlantic Health System (NJ) (Alberta, Canada)
Health Network Lab (PA) Lourdes Hospital (KY) Queensland Health Pathology Touro Infirmary (LA)
Health Partners Laboratories (VA) Maimonides Medical Center (NY) Services (Australia) Tripler Army Medical Center (HI)
Highlands Regional Medical Center Marion County Health Department Quest Diagnostics Incorporated Truman Medical Center (MO)
(FL) (IN) (CA) UCLA Medical Center (CA)
Hoag Memorial Hospital Martin Luther King/Drew Medical Quintiles Laboratories, Ltd. (GA) UCSF Medical Center (CA)
Presbyterian (CA) Center (CA) Regional Health Authority Four UNC Hospitals (NC)
Holy Cross Hospital (MD) Massachusetts General Hospital (NB, Canada) Unidad de Patologia Clinica
Hôpital du Sacré-Coeur de (Microbiology Laboratory) Regions Hospital (Mexico)
Montreal (Montreal, Quebec, MDS Metro Laboratory Services Rex Healthcare (NC) Union Clinical Laboratory (Taiwan)
Canada) (Burnaby, BC, Canada) Rhode Island Department of Health United Laboratories Company
Hôpital Maisonneuve - Rosemont Medical College of Virginia Laboratories (Kuwait)
(Montreal, Canada) Hospital Riverside Medical Center (IL) Universita Campus Bio-Medico
Hôpital Saint-Luc (Montreal, Medical University of South Robert Wood Johnson University (Italy)
Quebec, Canada) Carolina Hospital (NJ) University College Hospital
Hospital Consolidated Laboratories Memorial Medical Center Sahlgrenska Universitetssjukhuset (Galway, Ireland)
(MI) (Napoleon Avenue, New Orleans, (Sweden) University of Alabama-Birmingham
Hospital for Sick Children (Toronto, LA) St. Alexius Medical Center (ND) Hospital
ON, Canada) Methodist Hospital (Houston, TX) St. Anthony Hospital (CO) University of Chicago Hospitals
Hospital de Sousa Martins (Portugal) Methodist Hospital (San Antonio, St. Anthony’s Hospital (FL) (IL)
Hotel Dieu Grace Hospital (Windsor, TX) St. Barnabas Medical Center (NJ) University of Colorado Hospital
ON, Canada) Michigan Department of St. Christopher’s Hospital for University of Debrecen Medical
Huddinge University Hospital Community Health Children (PA) Health and Science Center
(Sweden) Mid America Clinical Laboratories, St-Eustache Hospital (Quebec, (Hungary)
Hunter Area Health Service LLC (IN) Canada) University of Illinois Medical Center
(Australia) Middlesex Hospital (CT) St. John Hospital and Medical University of Maryland Medical
Indiana University Monmouth Medical Center (NJ) Center (MI) System
Innova Fairfax Hospital (VA) Montreal Children’s Hospital St. John’s Hospital & Health Center University of Medicine & Dentistry,
Institute of Medical and Veterinary (Canada) (CA) NJ University Hospital
Science (Australia) Montreal General Hospital (Canada) St. Joseph Mercy Hospital (MI) University of the Ryukyus (Japan)
International Health Management National Serology Reference St. Joseph’s Hospital – Marshfield University of Wisconsin Hospital
Associates, Inc. (IL) Laboratory (Australia) Clinic (WI) The University of Texas Medical
Jackson Memorial Hospital (FL) NB Department of Health & St. Jude Children’s Research Branch
Jacobi Medical Center (NY) Wellness (New Brunswick, Hospital (TN) The University of the West Indies
John C. Lincoln Hospital (AZ) Canada) St. Mary of the Plains Hospital University of Virginia Medical
Johns Hopkins Medical Institutions The Nebraska Medical Center (TX) Center
(MD) New Britain General Hospital (CT) St. Mary Medical Center (CA) University of Washington
Kadlec Medical Center (WA) New England Fertility Institute (CT) St. Michael’s Hospital (Toronto, USA MEDDAC-AK
Kaiser Permanente (MD) New England Medical Center (MA) ON, Canada) US LABS, Inc. (CA)
Kangnam St. Mary’s Hospital New York City Department of Ste. Justine Hospital (Montreal, PQ, UZ-KUL Medical Center (Belgium)
(Korea) Health & Mental Hygiene Canada) VA (Tuskegee) Medical Center
Kantonsspital (Switzerland) NorDx (ME) Salem Clinic (OR) (AL)
Kimball Medical Center (NJ) North Carolina State Laboratory of San Francisco General Hospital Valley Children’s Hospital (CA)
King Abdulaziz Medical City – Public Health (CA) Virginia Beach General Hospital
Jeddah (Saudi Arabia) North Central Medical Center (TX) Santa Clara Valley Medical Center (VA)
King Faisal Specialist Hospital North Shore - Long Island Jewish (CA) Virginia Department of Health
(Saudi Arabia) Health System Laboratories (NY) Seoul Nat’l University Hospital Virginia Regional Medical Center
LabCorp (NC) North Shore University Hospital (Korea) (MN)
Laboratoire de Santé Publique du (NY) Shands at the University of Florida ViroMed Laboratories (MN)
Quebec (Canada) Northwestern Memorial Hospital South Bend Medical Foundation Washington Adventist Hospital
Laboratorio Dr. Echevarne (Spain) (IL) (IN) (MD)
Laboratório Fleury S/C Ltda. Ochsner Clinic Foundation (LA) South Western Area Pathology Washoe Medical Center
(Brazil) Onze Lieve Vrouw Ziekenhuis Service (Australia) Laboratory (NV)
Laboratorio Manlab (Argentina) (Belgium) Southern Maine Medical Center Waterford Regional Hospital
Laboratory Corporation of America Orlando Regional Healthcare System Spartanburg Regional Medical (Ireland)
(NJ) (FL) Center (SC) Wellstar Health Systems (GA)
LAC and USC Healthcare Ospedali Riuniti (Italy) Specialty Laboratories, Inc. (CA) West Jefferson Medical Center (LA)
Network (CA) The Ottawa Hospital State of Connecticut Dept. of Public Wilford Hall Medical Center (TX)
Lakeland Regional Medical Center (Ottawa, ON, Canada) Health William Beaumont Army Medical
(FL) OU Medical Center (OK) State of Washington Department of Center (TX)
Landstuhl Regional Medical Center Our Lady of the Resurrection Health William Beaumont Hospital (MI)
(APO AE) Medical Center (IL) Stony Brook University Hospital Winn Army Community Hospital
Lawrence General Hospital (MA) Pathology and Cytology (NY) (GA)
LeBonheur Children’s Medical Laboratories, Inc. (KY) Stormont-Vail Regional Medical Winnipeg Regional Health
Center (TN) Pathology Associates Medical Center (KS) Authority (Winnipeg, Canada)
Lewis-Gale Medical Center (VA) Laboratories (WA) Sun Health-Boswell Hospital (AZ) Wishard Memorial Hospital (IN)
L'Hotel-Dieu de Quebec (Canada) Peking University Shenzhen Sunnybrook Health Science Center Yonsei University College of
Libero Instituto Univ. Campus Hospital (China) (ON, Canada) Medicine (Korea)
BioMedico (Italy) The Permanente Medical Group Sunrise Hospital and Medical Center York Hospital (PA)
Lindy Boggs Medical Center (LA) (CA) (NV)
Loma Linda Mercantile (CA) Piedmont Hospital (GA) Swedish Medical Center -
Long Beach Memorial Medical Pocono Medical Center (PA) Providence Campus (WA)
Center (CA) Providence Health Care (Vancouver, Temple University Hospital (PA)
Louisiana State University BC, Canada) Tenet Odessa Regional Hospital
Medical Center Provincial Laboratory for Public (TX)
Health (Edmonton, AB, Canada) The Toledo Hospital (OH)
Thomas L. Hearn, Ph.D., Susan Blonshine, RRT, RPFT, FAARC Willie E. May, Ph.D.
President TechEd National Institute of Standards and Technology
Centers for Disease Control and Prevention
Kurt H. Davis, FCSMLS, CAE Gary L. Myers, Ph.D.
Robert L. Habig, Ph.D., Canadian Society for Medical Laboratory Science Centers for Disease Control and Prevention
President Elect
Abbott Laboratories Mary Lou Gantzer, Ph.D. Klaus E. Stinshoff, Dr.rer.nat.
Dade Behring Inc. Digene (Switzerland) Sàrl
Wayne Brinster,
Secretary Lillian J. Gill, D.P.A. James A. Thomas
BD FDA Center for Devices and Radiological Health ASTM International
Gerald A. Hoeltge, M.D., Carolyn D. Jones, J.D., M.P.H. Kiyoaki Watanabe, M.D.
Treasurer AdvaMed Keio University School of Medicine
The Cleveland Clinic Foundation
J. Stephen Kroger, M.D., MACP Judith A. Yost, M.A., M.T.(ASCP)
Donna M. Meyer, Ph.D., COLA Centers for Medicare & Medicaid Services
Immediate Past President
CHRISTUS Health